Form990


Department of the TreasuryInternal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private foundations)
Do not enter social security numbers on this form as it may be made public.
Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2023
Open to Public Inspection
A For the 2023 calendar year, or tax year beginning 01-01-2023 , and ending 12-31-2023
BCheck if applicable:
CName of organization
NOVO NORDISK FONDEN
 
 
Doing business as
 
 
Number and street (or P.O. box if mail is not delivered to street address)
TUBORG HAVNEVEJ 19
 
Room/suite
City or town, state or province, country, and ZIP or foreign postal code
HELLERUP2900
Denmark
D Employer identification number

98-1718091
E Telephone number

G Gross receipts $ 6,977,926,511
F Name and address of principal officer:
MADS KROGSGAARD THOMSEN
TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
I
Tax-exempt status: ( 4 ) (insert no.) or
J
Website:
HTTPS://NOVONORDISKFONDEN.DK/EN/
H(a)
Is this a group return for
subordinates?
H(b)
Are all subordinates
included?
If "No," attach a list. See instructions.
H(c)
Group exemption number  
K Form of organization:  
L Year of formation: 1989
M State of legal domicile: DA
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: NOVO NORDISK FONDEN (NNF) CONTRIBUTES SIGNIFICANTLY TO RESEARCH AND DEVELOPMENT THAT IMPROVES THE LIVES OF PEOPLE AND THE SUSTAINABILITY OF SOCIETY THROUGH GRANTMAKING.
2 Check this box
3 Number of voting members of the governing body (Part VI, line 1a) ........ 3 10
4 Number of independent voting members of the governing body (Part VI, line 1b) ..... 4 0
5 Total number of individuals employed in calendar year 2023 (Part V, line 2a) ...... 5 200
6 Total number of volunteers (estimate if necessary) ............. 6 0
7a Total unrelated business revenue from Part VIII, column (C), line 12 ........ 7a 0
b Net unrelated business taxable income from Form 990-T, Part I, line 11 ......... 7b 0
Revenues Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 0 0
9 Program service revenue (Part VIII, line 2g) ......... 0 0
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 5,042,532,061 82,297,396
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) 172,719 143,462,450
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12) 5,042,704,780 225,759,846
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 1,028,253,955 1,124,503,169
14 Benefits paid to or for members (Part IX, column (A), line 4)..... 0 0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10) 26,483,585 39,622,243
16a Professional fundraising fees (Part IX, column (A), line 11e) ..... 0 0
b Total fundraising expenses (Part IX, column (D), line 25) 0    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e).... 27,125,095 22,809,929
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 1,081,862,635 1,186,935,341
19 Revenue less expenses. Subtract line 18 from line 12....... 3,960,842,145 -961,175,495
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............. 8,723,601,012 8,537,586,696
21 Total liabilities (Part X, line 26)............. 3,076,022,422 3,348,212,575
22 Net assets or fund balances. Subtract line 21 from line 20..... 5,647,578,590 5,189,374,121
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
Signature of officer Date
Type or print name and title
Paid Preparer Use Only
Print/Type preparer's name
Preparer's signature
Date
PTIN
Firm's name

Firm's EIN
Firm's address



Phone no.
May the IRS discuss this return with the preparer shown above? See Instructions. ..........
For Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y Form 990 (2023)
Form 990 (2023)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response or note to any line in this Part III..............
1
Briefly describe the organization’s mission: NOVO NORDISK FONDEN (NNF) CONTRIBUTES SIGNIFICANTLY TO RESEARCH AND DEVELOPMENT THAT IMPROVES THE LIVES OF PEOPLE AND THE SUSTAINABILITY OF SOCIETY THROUGH GRANTMAKING.
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? .....................
If "Yes," describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program
services? ...........................
If "Yes," describe these changes on Schedule O.
4
Describe the organization’s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 1,144,541,990 including grants of $ 1,124,503,169 ) (Revenue $   )
NNF FOCUSES ITS GRANTMAKING PROGRAM TOWARD 3 MAIN OBJECTIVES:1. TO SUPPORT PHYSIOLOGICAL, ENDOCRINOLOGICAL, METABOLIC, AND OTHER MEDICAL RESEARCH. FOR 2023, 43% OF GRANTS WERE AWARDED FOR MEDICAL RESEARCH.2. TO SUPPORT RESEARCH HOSPITAL ACTIVITIES RELATED TO DIABETES IN DENMARK. FOR 2023, 0% OF GRANTS WERE AWARDED FOR RESEARCH HOSPITAL ACTIVITIES.3. TO SUPPORT OTHER SCIENTIFIC, HUMANITARIAN, AND SOCIAL PURPOSES. FOR 2023, 57% OF GRANTS WERE AWARDED FOR SUCH OTHER PURPOSES.
4b (Code:   ) (Expenses $   including grants of $   ) (Revenue $   )
4c (Code:   ) (Expenses $   including grants of $   ) (Revenue $   )
4d Other program services (Describe in Schedule O.)
(Expenses $   including grants of $   ) (Revenue $   )
4e Total program service expenses1,144,541,990
Form 990 (2023)
Form 990 (2023)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If "Yes," complete Schedule A.....................
1
 
No
2
Is the organization required to complete Schedule B, Schedule of Contributors? See instructions. ...
2
 
No
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If "Yes," complete Schedule C, Part I.............
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities, or have a section 501(h) election in effect during the tax year? If "Yes," complete Schedule C, Part II.........
4
 
 
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Rev. Proc. 98-19? If "Yes," complete Schedule C, Part III..
5
 
No
6
Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes," complete Schedule D, Part IClick to see attachment
List of Attached Documents:
// Content
.........................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas, or historic structures? If "Yes," complete Schedule D, Part IIClick to see attachment
List of Attached Documents:
// Content
....
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes,"
complete Schedule D, Part IIIClick to see attachment
List of Attached Documents:
// Content
..............
8
 
No
9
Did the organization report an amount in Part X, line 21 for escrow or custodial account liability; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," complete Schedule D, Part IVClick to see attachment
List of Attached Documents:
// Content
..............
9
 
No
10
Did the organization, directly or through a related organization, hold assets in temporarily restricted endowments, permanent endowments, or quasi endowments? If "Yes," complete Schedule D, Part V......
10
Yes
 
11
If the organization’s answer to any of the following questions is "Yes," then complete Schedule D, Parts VI, VII, VIII, IX, or X, as applicable.
a
Did the organization report an amount for land, buildings, and equipment in Part X, line 10? If "Yes," complete
Schedule D, Part VI. Click to see attachment
List of Attached Documents:
// Content
...................
11a
Yes
 
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIClick to see attachment
List of Attached Documents:
// Content
.......
11b
 
No
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIIClick to see attachment
List of Attached Documents:
// Content
.......
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part IXClick to see attachment
List of Attached Documents:
// Content
............
11d
 
No
e
Did the organization report an amount for other liabilities in Part X, line 25? If "Yes," complete Schedule D, Part XClick to see attachment
List of Attached Documents:
// Content
11e
Yes
 
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If "Yes," complete Schedule D, Part XClick to see attachment
List of Attached Documents:
// Content
11f
 
No
12a
Did the organization obtain separate, independent audited financial statements for the tax year? If "Yes," complete
Schedule D, Parts XI and XIIClick to see attachment
List of Attached Documents:
// Content
......................
12a
Yes
 
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If "Yes," and if the organization answered "No" to line 12a, then completing Schedule D, Parts XI and XII is optional Click to see attachment
List of Attached Documents:
// Content
12b
Yes
 
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If "Yes," complete Schedule E
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States? .....
14a
Yes
 
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States, or aggregate foreign investments valued at $100,000 or more? If "Yes," complete Schedule F, Parts I and IV.........Click to see attachment
List of Attached Documents:
// Content
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or other assistance to or for any foreign organization? If “Yes,” complete Schedule F, Parts II and IV.....Click to see attachment
List of Attached Documents:
// Content
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or other assistance to or for foreign individuals? If “Yes,” complete Schedule F, Parts III and IV...Click to see attachment
List of Attached Documents:
// Content
16
 
No
17
Did the organization report a total of more than $15,000 of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If "Yes," complete Schedule G, Part I. See instructions. ....
17
 
No
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If "Yes," complete Schedule G, Part II............
18
 
No
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If "Yes," complete Schedule G, Part III...................
19
 
No
20a
Did the organization operate one or more hospital facilities? If "Yes," complete Schedule H....
20a
 
No
b
If "Yes" to line 20a, did the organization attach a copy of its audited financial statements to this return?
20b
 
 
21
Did the organization report more than $5,000 of grants or other assistance to any domestic organization or domestic government on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II.....Click to see attachment
List of Attached Documents:
// Content
21
Yes
 
Form 990 (2023)
Form 990 (2023)
Page 4
Part IV
Checklist of Required Schedules (continued)
Yes
No
22
Did the organization report more than $5,000 of grants or other assistance to or for domestic individuals on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III........Click to see attachment
List of Attached Documents:
// Content
22
 
No
23
Did the organization answer "Yes" to Part VII, Section A, line 3, 4, or 5, about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If "Yes," complete Schedule J....................... Click to see attachment
List of Attached Documents:
// Content
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer lines 24b through 24d and complete Schedule K. If “No,” go to line 25a...............
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
 
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds? ...............
24c
 
 
d
Did the organization act as an "on behalf of" issuer for bonds outstanding at any time during the year?...
24d
 
 
25a
Section 501(c)(3), 501(c)(4), and 501(c)(29) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If "Yes," complete Schedule L, Part I ....
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If "Yes," complete Schedule L, Part I.......................
25b
 
No
26
Did the organization report any amount on Part X, line 5 or 22 for receivables from or payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons? If "Yes," complete Schedule L, Part II...........
26
 
No
27
Did the organization provide a grant or other assistance to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or employee thereof, a grant selection committee member, or to a 35% controlled entity (including an employee thereof) or family member of any of these persons?
If "Yes," complete
Schedule L, Part III.........................
27
 
No
28
Was the organization a party to a business transaction with one of the following parties (see the Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, key employee, creator or founder, or substantial contributor? If "Yes," complete Schedule L, Part IV......................
28a
 
No
b
A family member of any individual described in line 28a? If "Yes," complete Schedule L, Part IV.....
28b
 
No
c
A 35% controlled entity of one or more individuals and/or organizations described in line 28a or 28b? If "Yes," complete Schedule L, Part IV.....................
28c
 
No
29
Did the organization receive more than $25,000 in non-cash contributions? If "Yes," complete Schedule M..
29
 
No
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If "Yes," complete Schedule M .................
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If "Yes," complete Schedule N, Part I
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If "Yes," complete Schedule N, Part II........................
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If "Yes," complete Schedule R, Part I............Click to see attachment
List of Attached Documents:
// Content
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If "Yes," complete Schedule R, Part II, III, or IV, and Part V, line 1.........................Click to see attachment
List of Attached Documents:
// Content
34
Yes
 
35a
Did the organization have a controlled entity within the meaning of section 512(b)(13)?
35a
Yes
 
b
If ‘Yes’ to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If "Yes," complete Schedule R, Part V, line 2 ...Click to see attachment
List of Attached Documents:
// Content
35b
Yes
 
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If "Yes," complete Schedule R, Part V, line 2.............
36
 
 
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If "Yes," complete Schedule R, Part VIClick to see attachment
List of Attached Documents:
// Content
37
 
No
38
Did the organization complete Schedule O and provide explanations on Schedule O for Part VI, lines 11b and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response or note to any line in this Part V...........
Yes
No
1a
Enter the number reported in box 3 of Form 1096. Enter -0- if not applicable ..
1a
0
b
Enter the number of Forms W-2G included on line 1a. Enter -0- if not applicable .
1b
0
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
 
 
Form 990 (2023)
Form 990 (2023)
Page 5
Part V
Statements Regarding Other IRS Filings and Tax Compliance (continued)
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and
Tax Statements, filed for the calendar year ending with or within the year covered by this return ..................
2a
200
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?
2b
 
No
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?...
3a
 
No
b
If “Yes,” has it filed a Form 990-T for this year? If “No” to line 3b, provide an explanation in Schedule O...
3b
 
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account, securities account, or other financial account)? ..
4a
Yes
 
b
If "Yes," enter the name of the foreign country: DA
See instructions for filing requirements for FinCEN Form 114, Report of Foreign Bank and Financial Accounts (FBAR).
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year? ..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If "Yes," to line 5a or 5b, did the organization file Form 8886-T? ............
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible as charitable contributions? ...
6a
 
No
b
If "Yes," did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible? ......................
6b
 
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor? ....................
7a
 
No
b
If "Yes," did the organization notify the donor of the value of the goods or services provided? .....
7b
 
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282? .........................
7c
 
No
d
If "Yes," indicate the number of Forms 8282 filed during the year ....
7d
 
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?
7e
 
 
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ..
7f
 
 
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required? ......................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C? ..........................
7h
 
 
8
Sponsoring organizations maintaining donor advised funds. Did a donor advised fund maintained by the sponsoring organization have excess business holdings at any time during the year? ........
8
 
 
9
Sponsoring organizations maintaining donor advised funds.
a
Did the sponsoring organization make any taxable distributions under section 4966?........
9a
 
 
b
Did the sponsoring organization make a distribution to a donor, donor advisor, or related person?...
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources. (Do not net amounts due or paid to other sources against amounts due or received from them.) ..........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If "Yes," enter the amount of tax-exempt interest received or accrued during the year.
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state? .........
Note. See the instructions for additional information the organization must report on Schedule O.
13a
 
 
b
Enter the amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans ....
13b
 
c
Enter the amount of reserves on hand ............
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
No
b
If "Yes," has it filed a Form 720 to report these payments? If "No," provide an explanation in Schedule O..
14b
 
 
15
Is the organization subject to the section 4960 tax on payment(s) of more than $1,000,000 in remuneration or excess parachute payment(s) during the year? ....................
If "Yes," see the instructions and file Form 4720, Schedule N.
15
 
No
16
Is the organization an educational institution subject to the section 4968 excise tax on net investment income? ..
If "Yes," complete Form 4720, Schedule O.
16
 
No
17
Section 501(c)(21) organizations. Did the trust, or any disqualified or other person engage in any activities that would result in the imposition of an excise tax under section 4951, 4952, or 4953? ..
If "Yes," complete Form 6069.
17
 
 
Form 990 (2023)
Form 990 (2023)
Page 6
Part VI
Governance, Management, and Disclosure. For each "Yes" response to lines 2 through 7b below, and for a "No" response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response or note to any line in this Part VI..............
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year
1a
10
If there are material differences in voting rights among members of the governing body, or if the governing body delegated broad authority to an executive committee or similar committee, explain in Schedule O.
b
Enter the number of voting members included in line 1a, above, who are independent
1b
0
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
 
No
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? .
3
 
No
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed? .
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Did the organization have members or stockholders? ................
6
 
No
7a
Did the organization have members, stockholders, or other persons who had the power to elect or appoint one or more members of the governing body? ....................
7a
 
No
b
Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? ...................
7b
 
No
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .......................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ............
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If "Yes," provide the names and addresses in Schedule O.......
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal Revenue Code.)
Yes
No
10a
Did the organization have local chapters, branches, or affiliates? ............
10a
 
No
b
If "Yes," did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes?
10b
 
 
11a
Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form? ............................
11a
 
No
b
Describe on Schedule O the process, if any, used by the organization to review this Form 990. .....
12a
Did the organization have a written conflict of interest policy? If "No," go to line 13.......
12a
Yes
 
b
Were officers, directors, or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ..........................
12b
Yes
 
c
Did the organization regularly and consistently monitor and enforce compliance with the policy? If "Yes," describe on Schedule O how this was done...................
12c
Yes
 
13
Did the organization have a written whistleblower policy? ...............
13
Yes
 
14
Did the organization have a written document retention and destruction policy? .........
14
 
No
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
Yes
 
b
Other officers or key employees of the organization ................
15b
Yes
 
If "Yes" to line 15a or 15b, describe the process on Schedule O. See instructions.
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
Yes
 
b
If "Yes," did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
No
Section C. Disclosure
17
List the states with which a copy of this Form 990 is required to be filed
18
Section 6104 requires an organization to make its Form 1023 (1024 or 1024-A, if applicable), 990, and 990-T (section 501(c)(3)s only) available for public inspection. Indicate how you made these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year.
20
State the name, address, and telephone number of the person who possesses the organization's books and records:
EMIL CHRISTENSENTUBORG HAVNEVEJ 19   HELLERUP,   2900DA
Form 990 (2023)
Form 990 (2023)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response or note to any line in this Part VII..............
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See the instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (box 5 of Form W-2, box 6 of Form 1099-MISC, and/or box 1 of Form 1099-NEC) of more than $100,000 from the organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

See the instructions for the order in which to list the persons above.
Check this box if neither the organization nor any related organization compensated any current officer, director, or trustee.
(A)
Name and title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W-2/1099-MISC/1099-NEC) 		(E)
Reportable compensation from related organizations (W-2/1099-MISC/1099-NEC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(1) STEEN RIISGAARD......................................................................
DIRECTOR
 1.00
.................
1.00 		X           200,625 188,188 0
(2) MADS BORITZ GRON......................................................................
DIRECTOR
 1.00
.................
0.00 		X           61,594 0 0
(3) STIG STROBAEK......................................................................
DIRECTOR
 1.00
.................
0.00 		X           61,594 0 0
(4) LARS HENRIK FUGGER......................................................................
DIRECTOR
 1.00
.................
0.00 		X           85,580 0 0
(5) LISELOTTE HOJGAARD......................................................................
DIRECTOR
 1.00
.................
0.00 		X           80,102 0 0
(6) NANA SEJBAEK......................................................................
DIRECTOR (MAR-DEC)
 1.00
.................
0.00 		X           65,444 0 0
(7) OLE JAKOB MULLER......................................................................
DIRECTOR
 1.00
.................
0.00 		X           61,594 0 0
(8) CHRISTOPHER ASHBY VOIGT......................................................................
DIRECTOR (MAR-DEC)
 1.00
.................
0.00 		X           83,803 0 0
(9) LARS REBIEN SORENSEN......................................................................
CHAIR
 1.00
.................
1.00 		X   X       277,173 276,729 0
(10) MARIANNE PHILIP......................................................................
VICE CHAIR (JAN-MAR)
 1.00
.................
0.00 		X   X       30,797 0 0
(11) LARS HENRIK MUNCH......................................................................
VICE CHAIR
 1.00
.................
0.00 		X   X       140,808 0 0
(12) MADS KROGSGAARD THOMSEN......................................................................
CEO
 40.00
.................
0.00 		    X       1,163,061 0 284,103
(13) ERIKA SODERBERG JOHNSSON......................................................................
CFO
 40.00
.................
0.00 		    X       373,606 0 0
(14) SOREN NEDERGAARD......................................................................
COO
 40.00
.................
0.00 		    X       462,844 0 61,564






Form 990 (2023)
Form 990 (2023)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W-2/1099-MISC/1099-NEC) 		(E)
Reportable compensation from related organizations (W-2/1099-MISC/1099-NEC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;


























1b Sub-Total..............
c Total from continuation sheets to Part VII, Section A..
d Total (add lines 1b and 1c)......... 3,148,625 464,917 345,667
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the organization 6
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If "Yes," complete Schedule J for such individual ..............
3
 
No
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If "Yes," complete Schedule J for such
individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If "Yes," complete Schedule J for such person ........
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report compensation for the calendar year ending with or within the organization’s tax year.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization 0
Form 990 (2023)
Form 990 (2023)
Page 9
Part VIII
Statement of Revenue
Check if Schedule O contains a response or note to any line in this Part VIII.............
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512 - 514
Contributions, Gifts, Grants, and OtherAmt Similar Amounts 1a Federated campaigns..1a  
b Membership dues..1b  
c Fundraising events..1c  
d Related organizations1d  
e Government grants (contributions)1e  
f All other contributions, gifts, grants, and similar amounts not included above1f  
g Noncash contributions included in lines 1a - 1f:$ 1g  
h Total. Add lines 1a-1f.......  
Program Service RevenueAmt Business Code
2a
b
c
d
e
f All other program service revenue.        
g Total. Add lines 2a–2f .....  
OtherAmtRevenueAmt 3 Investment income (including dividends, interest, and othersimilar amounts) ...... 25,263,535     25,263,535
4 Income from investment of tax-exempt bond proceeds        
5 Royalties...........        
(i) Real (ii) Personal
6a Gross rents 6a    
b Less: rental expenses 6b    
c Rental income or (loss) 6c    
d Net rental income or (loss).......        
(i) Securities (ii) Other
7a Gross amount from sales of assets other than inventory 7a 6,809,200,526  
b Less: cost or other basis and sales expenses 7b 6,752,166,665  
c Gain or (loss) 7c 57,033,861  
d Net gain or (loss)......... 57,033,861     57,033,861
8a Gross income from fundraising events (not including $   of contributions reported on line 1c). See Part IV, line 18 ....
8a  
b Less: direct expenses ... 8b  
c Net income or (loss) from fundraising events..      
9a Gross income from gaming activities.
See Part IV, line 19 ...
9a  
b Less: direct expenses ... 9b  
c Net income or (loss) from gaming activities..        
10a Gross sales of inventory, less
returns and allowances ..
10a  
b Less: cost of goods sold .. 10b  
c Net income or (loss) from sales of inventory..        
OtherRevenueMiscAmt
Business Code
11a INTEREST GROUP   139,184,582     139,184,582
b SHARED SERVICES   4,062,471     4,062,471
c PRIOR YEAR TAX ADJUSTMENTS   215,397     215,397
d All other revenue ....        
e Total. Add lines 11a–11d ...... 143,462,450
12 Total revenue. See instructions..... 225,759,846 0 0 225,759,846
Form 990 (2023)
Form 990 (2023)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A).Check if Schedule O contains a response or note to any line in this Part IX..............
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising
expenses
1 Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21 .... 28,041,733 28,041,733
2 Grants and other assistance to domestic individuals. See Part IV, line 22 ...........    
3 Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, lines 15 and 16. ............. 1,096,461,436 1,096,461,436
4 Benefits paid to or for members .......    
5 Compensation of current officers, directors, trustees, and key employees ........... 2,306,667   2,306,667  
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) .........        
7 Other salaries and wages........ 31,223,485 12,489,394 18,734,091  
8 Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) .... 4,323,994 1,729,598 2,594,396  
9 Other employee benefits ....... 1,768,097 707,239 1,060,858  
10 Payroll taxes ...........        
11 Fees for services (non-employees):        
a Management ......        
b Legal ......... 457,530   457,530  
c Accounting ........... 352,941   352,941  
d Lobbying ........... 841,384 841,384    
e Professional fundraising services. See Part IV, line 17    
f Investment management fees ......        
g Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) 11,069,752 4,427,901 6,641,851  
12 Advertising and promotion .... 102,498   102,498  
13 Office expenses ....... 597,085 238,834 358,251  
14 Information technology ...... 1,743,186 697,274 1,045,912  
15 Royalties ..        
16 Occupancy ........... 999,417 399,767 599,650  
17 Travel ............ 3,421,194 1,368,478 2,052,716  
18 Payments of travel or entertainment expenses for any federal, state, or local public officials .        
19 Conferences, conventions, and meetings .... 390,007 156,003 234,004  
20 Interest ........... -191,236   -191,236  
21 Payments to affiliates ....... 10,568,798   10,568,798  
22 Depreciation, depletion, and amortization .. 369,213 147,685 221,528  
23 Insurance ...        
24 Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a CAPITALIZED PROJECT COS -7,911,840 -3,164,736 -4,747,104  
b
c
d
e All other expenses        
25 Total functional expenses. Add lines 1 through 24e 1,186,935,341 1,144,541,990 42,393,351 0
26 Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here if following SOP 98-2 (ASC 958-720).        
Form 990 (2023)
Form 990 (2023)
Page 11
Part X
Balance Sheet
Check if Schedule O contains a response or note to any line in this Part IX..............
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash–non-interest-bearing ........ 3,310,147 1 6,289,565
2 Savings and temporary cash investments .........   2  
3 Pledges and grants receivable, net ......   3  
4 Accounts receivable, net ............. 1,226,765 4 4,942,135
5 Loans and other receivables from any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .......
  5  
6 Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), and persons described in section 4958(c)(3)(B) ...
  6  
7 Notes and loans receivable, net ........... 4,448,619,234 7 3,492,083,920
8 Inventories for sale or use ............   8  
9 Prepaid expenses and deferred charges ......   9  
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a 5,828,041
b Less: accumulated depreciation 10b 170,804 649,843 10c 5,657,237
11 Investments—publicly traded securities . 3,947,109,760 11 4,662,711,031
12 Investments—other securities. See Part IV, line 11 ..... 213,223 12 41,939,735
13 Investments—program-related. See Part IV, line 11 .. 317,168,875 13 317,168,875
14 Intangible assets ............... 2,968,555 14 4,492,676
15 Other assets. See Part IV, line 11 ........... 2,334,610 15 2,301,522
16 Total assets. Add lines 1 through 15 (must equal line 33)... 8,723,601,012 16 8,537,586,696
Liabilities 17 Accounts payable and accrued expenses ..... 1,106,505 17 2,696,385
18 Grants payable ... 3,065,338,048 18 3,334,925,094
19 Deferred revenue .........   19  
20 Tax-exempt bond liabilities .........   20  
21 Escrow or custodial account liability. Complete Part IV of Schedule D   21  
22 Loans and other payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .........
  22  
23 Secured mortgages and notes payable to unrelated third parties ..   23  
24 Unsecured notes and loans payable to unrelated third parties ..   24  
25 Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17 - 24). Complete Part X of Schedule D 9,577,869 25 10,591,096
26 Total liabilities. Add lines 17 through 25.. 3,076,022,422 26 3,348,212,575
Net Assets or Fund Balance Organizations that follow FASB ASC 958, check here and complete lines 27, 28, 32, and 33.
27 Net assets without donor restrictions ..........   27  
28 Net assets with donor restrictions ...........   28  
Organizations that do not follow FASB ASC 958, check here right arrow and complete lines 29 through 33.
29 Capital stock or trust principal, or current funds ..... 3,231,658 29 3,231,658
30 Paid-in or capital surplus, or land, building or equipment fund ... 0 30 0
31 Retained earnings, endowment, accumulated income, or other funds 5,644,346,932 31 5,186,142,463
32 Total net assets or fund balances ........... 5,647,578,590 32 5,189,374,121
33 Total liabilities and net assets/fund balances ........ 8,723,601,012 33 8,537,586,696
Form 990 (2023)
Form 990 (2023)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response or note to any line in this Part XI..............
1
Total revenue (must equal Part VIII, column (A), line 12) ............
1
225,759,846
2
Total expenses (must equal Part IX, column (A), line 25) ............
2
1,186,935,341
3
Revenue less expenses. Subtract line 2 from line 1 ..............
3
-961,175,495
4
Net assets or fund balances at beginning of year (must equal Part X, line 32, column (A)) ..
4
5,647,578,590
5
Net unrealized gains (losses) on investments ...............
5
503,005,766
6
Donated services and use of facilities .................
6
 
7
Investment expenses .....................
7
 
8
Prior period adjustments .....................
8
 
9
Other changes in net assets or fund balances (explain in Schedule O) ........
9
-34,740
10
Net assets or fund balances at end of year. Combine lines 3 through 9 (must equal Part X, line 32, column (B))
10
5,189,374,121
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response or note to any line in this Part XII.............
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain on
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?
2a
 
No
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were compiled or reviewed on a separate basis, consolidated basis, or both:
b
Were the organization’s financial statements audited by an independent accountant?
2b
Yes
 
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were audited on a separate basis, consolidated basis, or both:
c
If "Yes," to line 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?
2c
Yes
 
If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O.
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Uniform Guidance, 2 C.F.R. Part 200, Subpart F?
3a
 
No
b
If "Yes," did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits.
3b
 
 
Form 990 (2023)
Form 990 (2023)
Additional Data


Software ID:  
Software Version:  
Form 990, Special Condition Description:
Special Condition Description
SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
right arrow Complete if the organization answered "Yes," on Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
right arrow Attach to Form 990.
right arrow Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2022
Open to Public Inspection
Name of the organization
NOVO NORDISK FONDEN
 
Employer identification number

98-1718091
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" on Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year .........    
2 Aggregate value of contributions to (during year)    
3 Aggregate value of grants from (during year)    
4 Aggregate value at end of year ........    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised funds are the organization’s property, subject to the organization’s exclusive legal control? ............
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................
Part II
Conservation Easements.
Complete if the organization answered "Yes" on Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ...................... 2a  
b Total acreage restricted by conservation easements .................... 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after July 25, 2006, and not on a historic structure listed in the National Register ... 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during the
tax year right arrow  
4
Number of states where property subject to conservation easement is located right arrow  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and enforcement of the conservation easements it holds? ............
6
Staff and volunteer hours devoted to monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
right arrow  
7
Amount of expenses incurred in monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
right arrow $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .............................
9
In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" on Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under FASB ASC 958, not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under FASB ASC 958, to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:
(i)
Revenue included on Form 990, Part VIII, line 1 .........................right arrow $  
(ii)
Assets included in Form 990, Part X ...............................right arrow $  
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under FASB ASC 958 relating to these items:
a
Revenue included on Form 990, Part VIII, line 1 ..........................right arrow $  
b
Assets included in Form 990, Part X ...............................right arrow $  
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 52283D
Schedule D (Form 990) 2022

Schedule D (Form 990) 2022
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):
a
d
b
e
 
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?...
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" on Form 990, Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b If "Yes," explain the arrangement in Part XIII and complete the following table: Amount
c Beginning balance ............................. 1c  
d Additions during the year ............................ 1d  
e Distributions during the year .......................... 1e  
f Ending balance ................................ 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability? ...
b
If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ....
Part V
Endowment Funds.
Complete if the organization answered "Yes" on Form 990, Part IV, line 10.
(a) Current year (b) Prior year (c) Two years back (d) Three years back (e) Four years back
1a Beginning of year balance .... 18,849,929,666 23,493,151,699 19,446,805,360 16,863,996,446 14,302,213,667
b Contributions ...          
c Net investment earnings, gains, and losses 3,765,603,021 983,490,042 4,934,774,561 3,767,379,877 3,420,596,728
d Grants or scholarships ...   5,626,712,075 888,428,222 1,184,570,963 858,813,948
e Other expenditures for facilities
and programs ... 		         
f Administrative expenses ....          
g End of year balance ...... 22,615,532,687 18,849,929,666 23,493,151,699 19,446,805,360 16,863,996,447
2
Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:
a
Board designated or quasi-endowment right arrow100.000 %
b
Permanent endowment right arrow  
c
Term endowment right arrow  
The percentages on lines 2a, 2b, and 2c should equal 100%.
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) Unrelated organizations .................
3a(i)
 
No
(ii) Related organizations .................
3a(ii)
Yes
 
b
If "Yes" on 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
Yes
 
4
Describe in Part XIII the intended uses of the organization's endowment funds.
Part VI
Land, Buildings, and Equipment.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11a. See Form 990, Part X, line 10.
Description of property (a) Cost or other basis
(investment) 		(b) Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land .....      
b Buildings ....        
c Leasehold improvements   5,828,041 170,804 5,657,237
d Equipment ....        
e Other .....        
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).)..right arrow 5,657,237
Schedule D (Form 990) 2022

Schedule D (Form 990) 2022
Page 3
Part VII
Investments - Other Securities.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11b. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(1) Financial derivatives.........    
(2) Closely-held equity interests........    
(3)Other
(A)
(B)
(C)
(D)
(E)
(F)
(G)
(H)
Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)right arrow  
Part VIII
Investments - Program Related. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11c. See Form 990, Part X, line 13.
(a) Description of investment (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)right arrow  
Part IX
Other Assets.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11d. See Form 990, Part X, line 15.
(a) Description (b) Book value
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........right arrow  
Part X
Other Liabilities.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.
1.(a) Description of liability (b) Book value
(1) Federal income taxes  
ACCRUED EMPLOYEE COSTS 7,637,618
ACCOUNTS PAYABLE, GROUP COMPANIES 2,938,218
VAT 15,260






Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)right arrow 10,591,096
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII
Schedule D (Form 990) 2022

Schedule D (Form 990) 2022
Page 4
Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total revenue, gains, and other support per audited financial statements ....... 1 724,487,744
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains (losses) on investments .... 2a 503,005,766
b Donated services and use of facilities ......... 2b  
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIII.) ........... 2d  
e Add lines 2a through 2d ..................... 2e 503,005,766
3 Subtract line 2e from line 1.................. 3 221,481,978
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a  
b Other (Describe in Part XIII.) ........... 4b 4,277,868
c Add lines 4a and 4b.................... 4c 4,277,868
5 Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ...... 5 225,759,846
Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total expenses and losses per audited financial statements ........... 1 1,182,694,897
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities ......... 2a  
b Prior year adjustments ............ 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIII.) ........... 2d 37,424
e Add lines 2a through 2d.................... 2e 37,424
3 Subtract line 2e from line 1................... 3 1,182,657,473
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a  
b Other (Describe in Part XIII.) ........... 4b 4,277,868
c Add lines 4a and 4b..................... 4c 4,277,868
5 Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ...... 5 1,186,935,341
Part XIII
Supplemental Information
Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b; Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.
Return Reference Explanation
PART V, LINE 4: NOVO HOLDINGS HOLDS AND MAINTAINS ENDOWMENT FUNDS IN ORDER TO FURTHER NOVO NORDISK FONDEN'S GRANTMAKING PROGRAMS RELATED TO MEDICAL RESEARCH, RESEARCH HOSPITAL ACTIVITIES, AND OTHER HUMANITARIAN AND SOCIAL PURPOSES.
PART XI, LINE 4B - OTHER ADJUSTMENTS: SLA SHARED SERVICES AND TAX ADJUSTMENT 4,277,868.
PART XII, LINE 2D - OTHER ADJUSTMENTS: FX ADJUSTMENT 37,424.
PART XII, LINE 4B - OTHER ADJUSTMENTS: SLA SHARED SERVICES AND TAX ADJUSTMENT 4,277,868.
Schedule D (Form 990) 2022


Additional Data


Software ID:  
Software Version:  




SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right arrow Complete if the organization answered "Yes" to Form 990, Part IV, line 14b, 15, or 16.Right arrow Attach to Form 990.Right arrow Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2023
Open to Public Inspection
Name of the organization
NOVO NORDISK FONDEN
 
Employer identification number

98-1718091
Part I
General Information on Activities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of its grants and
other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used
to award the grants or assistance? . . . . . . . . . . . . . . . . . . . . . . . . .
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.
3
Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees, agents, and independent contractors in the region (d) Activities conducted in region (by type) (such as, fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in the region		 (f) Total expenditures
for and investments
in the region
EAST ASIA AND THE PACIFIC     GRANTMAKING   2,722,361
EUROPE (INCLUDING ICELAND & GREENLAND)     GRANTMAKING   1,094,033,449
MIDDLE EAST AND NORTH AFRICA     GRANTMAKING   74,031
NORTH AMERICA     GRANTMAKING   384,349
SOUTH ASIA     GRANTMAKING   2,007,864
SUB-SAHARAN AFRICA     GRANTMAKING   2,368,560
EUROPE (INCLUDING ICELAND & GREENLAND) 1 200 OPERATIONAL EXPENSES   62,432,172
           
           
           
           
           
           
           
           
           
           
3a Sub-total .... 1 200 1,164,022,786
b Total from continuation sheets to Part I ... 0 0 0
c Totals (add lines 3a and 3b) 1 200 1,164,022,786
For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2023
Schedule F (Form 990) 2023
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount
of noncash
assistance 		(h) Description
of noncash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 514,019 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 22,209 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 444,188 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 1,180,564 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 3,822,545 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 4,513,024 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 4,257,957 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 1,479,657 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 147,841 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 88,838 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 20,729 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 5,614,186 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 1,028,151 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 4,341,936 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 740,313 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 29,613 EFT 0    
SUB-SAHARAN AFRICA SOCHUM 710,606 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 616,379 EFT 0    
SUB-SAHARAN AFRICA SOCHUM 726,786 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 42,346 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 295,038 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 161,103 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 39,296 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 592,102 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 64,555,294 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 22,209 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 309,469 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 737,603 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 1,588,478 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 735,508 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 148,063 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 20,866,708 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 681,791 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 1,568,560 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 1,168,773 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INFDIS 232,889 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 4,624,541 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 560,453 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 590,682 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 2,623,088 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 14,584 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 225,795 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 766,224 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 32,573,772 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 859,664 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 210,617 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 739,217 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 342,741 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 2,294,970 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INFDIS 1,943,175 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 485,747 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 2,278,017 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 37,016 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 71,720 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) O&NS 118,450 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 1,154,888 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 518,219 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 42,790 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 1,618,507 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 16,851,012 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 3,630,442 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 29,613 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 182,487 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 7,891,737 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 1,998,845 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 666,282 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 225,795 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 519,789 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 1,850,783 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 171,060 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 666,282 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 1,594,443 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 316,451 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 74,031 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 14,884 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INFDIS 2,044,828 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 500,539 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 265,624 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 740,313 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 37,016 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 37,016 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 74,031 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 33,394 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 78,666 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 275,051 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 296,124 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 1,168,014 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 666,282 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 399,769 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 1,722,014 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 4,604,747 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 738,092 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 519,459 EFT 0    
SOUTH ASIA BIOTECH 1,425,786 EFT 0    
NORTH AMERICA BIOTECH 230,886 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 740,283 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 814,344 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 70,330 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 1,332,563 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 4,840,905 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 123,284 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 378,478 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 88,838 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 426,776 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 740,313 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 29,982,677 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 98,610 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 888,376 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 771,937 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 1,018,404 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 1,164,796 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 82,270 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 88,838 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 1,314,056 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 556,798 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 88,838 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 88,838 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 177,675 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 610,625 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 736,497 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 2,764,780 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) O&NS 44,419 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 345,098 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 1,387,486 EFT 0    
SUB-SAHARAN AFRICA SOCHUM 475,863 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 2,218,044 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 465,327 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 444,188 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 88,838 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 543,062 EFT 0    
SOUTH ASIA SOCHUM 582,078 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 740,313 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 148,063 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 148,063 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 740,301 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 649,914 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 294,527 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 8,128,622 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 88,838 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 37,016 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 296,125 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 436,507 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 666,282 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 59,090 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 16,013 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 1,275,644 EFT 0    
NORTH AMERICA MEDSCI 103,052 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 77,733 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 739,873 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 1,690,875 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 733,459 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 325,734 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 1,332,563 EFT 0    
SUB-SAHARAN AFRICA INFDIS 455,304 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INFDIS 33,085 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 7,582,014 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 281,319 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 2,386,343 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 369,991 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 1,793,144 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 88,838 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 2,197,675 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 88,838 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 147,037 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 592,250 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 117,887 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 499,267 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 675,664 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 99,276 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) O&NS 44,419 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 735,457 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INFDIS 1,424,313 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 669,298 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 6,075,751 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 97,752 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 201,661 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 2,330,570 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 290,721 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 672,081 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 863,460 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 4,111,446 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 3,622,102 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 12,321,676 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 17,692,083 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 144,657 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 444,188 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 184,856 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 193,281 EFT 0    
NORTH AMERICA MEDSCI 50,411 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 37,016 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 218,137 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 392,247 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 148,063 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 420,690 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 163,953 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 740,313 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 735,218 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 1,626,800 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 1,435,378 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 14,806,260 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 37,016 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 22,294,205 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 7,801,541 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 41,112,702 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 43,096,668 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 17,641,285 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 296,125 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 1,633,443 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 740,313 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 21,433,401 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 6,899,286 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INFDIS 210,575,533 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 12,977,125 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 208,704,368 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 69,617,795 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) O&NS 304,701 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 759,930 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 216,711 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 740,313 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 2,456,359 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) O&NS 44,419 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 592,120 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) O&NS 44,419 EFT 0    
EAST ASIA AND THE PACIFIC INFDIS 2,048,359 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 444,188 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 1,772,280 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 296,029 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INFDIS 2,466,174 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 814,344 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 843,267 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 672,627 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 7,608,551 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) NAT-TECH 9,219,847 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 733,265 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 148,063 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 1,957,309 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 793,986 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) INNOVATION 294,764 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 2,256,350 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 88,838 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 37,016 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 799,066 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 162,955 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 37,016 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) BIOTECH 947,600 EFT 0    
MIDDLE EAST AND NORTH AFRICA MEDSCI 74,031 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) MEDSCI 641,281 EFT 0    
EAST ASIA AND THE PACIFIC O&NS 674,002 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 2,539,951 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 1,110,470 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) SOCHUM 2,294,970 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 731,385 EFT 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) E&O 297,199 EFT 0    
2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .......MediumBullet
200
3 Enter total number of other organizations or entities .......................MediumBullet
 
Schedule F (Form 990) 2023
Schedule F (Form 990) 2023Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 16.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
noncash
assistance 		(g) Description
of noncash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2023
Schedule F (Form 990) 2023
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to separately file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A; don't file with Form 990). . . . . . . . . . . . . . . . . . . . . . . .
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471). . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621) .
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships (see Instructions for Form 8865). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713; don't file with Form 990).. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule F (Form 990) 2023
Schedule F (Form 990) 2023
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information. See instructions.
ReturnReference Explanation
PART I, LINE 2: NNF'S GRANTS ARE PARTLY AWARDED THROUGH OPEN CALLS AND PARTLY THROUGH STRATEGIC ONE-OFF INITIATIVES THAT ARE APPROVED BY NNF'S BOARD OF DIRECTORS. NNF AWARDS GRANTS IN OPEN COMPETITION WITHIN THE SEVEN GRANT-AWARDING FOCUS STRATEGIES. ALL GRANTS AWARDED IN OPEN COMPETITION ARE PEER REVIEWED BY COMMITTEES THAT HAVE BEEN ESTABLISHED BY NNF'S BOARD OF DIRECTORS. THESE 24 COMMITTEES ARE COMPRISED OF 5 TO 12 MEMBERS WHO ARE INTERNATIONALLY RECOGNIZED EXPERTS IN THEIR FIELD, AND WHO EVALUATE THE GRANTS BASED ON QUALITY, NOVELTY, POTENTIAL IMPACT, BUDGET, AND QUALIFICATIONS OF THE APPLICANT. FOR A LIST OF THESE COMMITTEES, SEE HTTPS://NOVONORDISKFONDEN.DK/EN/COMMITTEES. EACH COMMITTEE EVALUATES EACH APPLICATION ASSIGNED TO IT VERY CAREFULLY. FIRST, THE MEMBERS OF THE COMMITTEE EVALUATE THE APPLICATIONS INDIVIDUALLY AND GIVE THEM A SCORE. AFTER THIS, THE COMMITTEE MEETS TO DISCUSS THE HIGHEST-RANKING APPLICATIONS TO REACH CONSENSUS ON GRANTING RECOMMENDATIONS. THE EVALUATION PROCESS OF SOME CALLS MAY INCLUDE AN ADDITIONAL ELABORATED APPLICATION, A PERSONAL INTERVIEW WITH THE APPLICANT, OR THE USE OF FURTHER EXPERT PEER REVIEW. NNF POSTS ITS OPEN COMPETITION CALLS FOR APPLICATIONS HERE - HTTPS://NOVONORDISKFONDEN.DK/EN/GRANT/ - AND INTERESTED APPLICANTS APPLY ON-LINE USING NORMA, NNF'S APPLICATION AND GRANT MANAGEMENT SYSTEM. THE ENTIRE EVALUATION PROCESS IS CLOSELY MONITORED BY NNF'S BOARD OF DIRECTORS, WHICH HAS SET RULES OF PROCEDURES FOR EACH COMMITTEE THAT FOLLOW THE BEST INTERNATIONAL STANDARDS. IN ADDITION, THE SECRETARIAT OVERSEES THAT IT IS CARRIED OUT IN ACCORDANCE WITH NNF'S RULES AND POLICIES, INCLUDING THE RULES OF ELIGIBILITY TO ENSURE FULL IMPARTIALITY OF COMMITTEE MEMBERS. UNDER THESE RULES OF ELIGIBILITY, INDIVIDUALS ARE INELIGIBLE TO ASSESS AN APPLICATION IF THEY HAVE A PERSONAL, PROFESSIONAL, OR FINANCIAL INTEREST IN THE OUTCOME OF AN APPLICATION: FOR EXAMPLE, IF THE MEMBER SUPERVISES THE APPLICANT; IS EMPLOYED IN THE SCIENTIFIC UNIT OF WHICH THE APPLICANT IS A LEADER; OR IF THE MEMBER HAS A FAMILY RELATIONSHIP TO THE APPLICANT. NNF SYSTEMATICALLY COLLECTS DATA ON THE ACTIVITIES, OUTPUTS AND OUTCOMES OF EACH GRANT RECIPIENT'S PROJECT THROUGH ITS TWO ONLINE DATA-COLLECTION AND REPORTING SYSTEMS RESEARCHFISH AND FOUNDGOOD. THE TWO SYSTEMS ENABLE NNF TO SYSTEMATICALLY MONITOR THE ACTIVITIES OF ITS GRANT RECIPIENTS AND THE RESULTS OF THEIR WORK. SINCE ALL GRANT RECIPIENTS REPORT ANNUALLY, NNF HAS DATA ON THE FULL POPULATION WITH NO ATTRITION. IT IS MANDATORY FOR ALL GRANT RECIPIENTS TO USE NNF'S WEB-BASED SURVEY SYSTEMS (RESEARCHFISH AND FOUNDGOOD) FOR REPORTING ON ACTIVITIES AND RESULTS RELEVANT TO THEIR GRANT. THE GRANT RECIPIENTS REPORT ANNUALLY FOR THE DURATION OF THE PROJECT AND 1-5 YEARS AFTER THE PROJECT ENDS. NNF USES DATA IN EVALUATING TYPES OF GRANTS AND FUNDING INSTRUMENTS - WHAT WORKS AND WHAT DOES NOT WORK - TO SUPPORT THE BOARD IN ITS DECISIONS ON GRANT POLICY AND GRANT-AWARDING.
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Schedule F (Form 990) 2023
Additional Data


Software ID:  
Software Version:  




Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," on Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990.
lBullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2023
Open to Public
Inspection
Name of the organization
NOVO NORDISK FONDEN
 
Employer identification number
98-1718091
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ........................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" on Form 990, Part IV, line 21, for any recipient
that received more than $5,000. Part II can be duplicated if additional space is needed.
(a) Name and address of organization
or government		 (b) EIN (c) IRC section
(if applicable)		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
noncash assistance		 (h) Purpose of grant
or assistance
(1) BOSTON UNIVERSITY

 
  		04-2103547 501(C)(3) 25,205,437 0     INFDIS
(2) BOSTON CHILDREN'S HOSPITAL

 
  		04-2774441 501(C)(3) 128,415 0     O&NS
(3) FOUNDATION FOR FOOD & AGRICULTURE RESEARCH (FFAR)

 
  		47-1559027 501(C)(3) 1,006,737 0     BIOTECH
(4) INTERNATIONAL RESCUE COMMITTEE

 
  		13-5660870 501(C)(3) 738,737 0     SOCHUM
(5) JOSLIN DIABETES CENTER

 
  		04-2203836 501(C)(3) 148,063 0     MEDSCI
(6) UNIVERSITY OF MICHIGAN MEDICAL SCHOOL

 
  		38-6006309 115 74,031 0     MEDSCI
(7) US NATIONAL ACADEMY OF SCIENCES

 
  		53-0196932 501(C)(3) 740,313 0     NAT-TECH
2
Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image
7
3
Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2023

Schedule I (Form 990) 2023
Page 2
Part III
Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" on Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Number of
recipients		 (c) Amount of
cash grant		 (d) Amount of
noncash assistance		 (e) Method of valuation (book,
FMV, appraisal, other)		 (f) Description of noncash assistance
(1)
(2)
(3)
(4)
(5)
(6)
(7)
Part IV
Supplemental Information. Provide the information required in Part I, line 2; Part III, column (b); and any other additional information.
Return Reference Explanation
PART I, LINE 2: NNF'S GRANTS ARE PARTLY AWARDED THROUGH OPEN CALLS AND PARTLY THROUGH STRATEGIC ONE-OFF INITIATIVES THAT ARE APPROVED BY NNF'S BOARD OF DIRECTORS. NNF AWARDS GRANTS IN OPEN COMPETITION WITHIN THE SEVEN GRANT-AWARDING FOCUS STRATEGIES. ALL GRANTS AWARDED IN OPEN COMPETITION ARE PEER REVIEWED BY COMMITTEES THAT HAVE BEEN ESTABLISHED BY NNF'S BOARD OF DIRECTORS. THESE 24 COMMITTEES ARE COMPRISED OF 5 TO 12 MEMBERS WHO ARE INTERNATIONALLY RECOGNIZED EXPERTS IN THEIR FIELD, AND WHO EVALUATE THE GRANTS BASED ON QUALITY, NOVELTY, POTENTIAL IMPACT, BUDGET, AND QUALIFICATIONS OF THE APPLICANT. FOR A LIST OF THESE COMMITTEES, SEE HTTPS://NOVONORDISKFONDEN.DK/EN/COMMITTEES. EACH COMMITTEE EVALUATES EACH APPLICATION ASSIGNED TO IT VERY CAREFULLY. FIRST, THE MEMBERS OF THE COMMITTEE EVALUATE THE APPLICATIONS INDIVIDUALLY AND GIVE THEM A SCORE. AFTER THIS, THE COMMITTEE MEETS TO DISCUSS THE HIGHEST-RANKING APPLICATIONS TO REACH CONSENSUS ON GRANTING RECOMMENDATIONS. THE EVALUATION PROCESS OF SOME CALLS MAY INCLUDE AN ADDITIONAL ELABORATED APPLICATION, A PERSONAL INTERVIEW WITH THE APPLICANT, OR THE USE OF FURTHER EXPERT PEER REVIEW. NNF POSTS ITS OPEN COMPETITION CALLS FOR APPLICATIONS HERE - HTTPS://NOVONORDISKFONDEN.DK/EN/GRANT/ - AND INTERESTED APPLICANTS APPLY ON-LINE USING NORMA, NNF'S APPLICATION AND GRANT MANAGEMENT SYSTEM. THE ENTIRE EVALUATION PROCESS IS CLOSELY MONITORED BY NNF'S BOARD OF DIRECTORS, WHICH HAS SET RULES OF PROCEDURES FOR EACH COMMITTEE THAT FOLLOW THE BEST INTERNATIONAL STANDARDS. IN ADDITION, THE SECRETARIAT OVERSEES THAT IT IS CARRIED OUT IN ACCORDANCE WITH NNF'S RULES AND POLICIES, INCLUDING THE RULES OF ELIGIBILITY TO ENSURE FULL IMPARTIALITY OF COMMITTEE MEMBERS. UNDER THESE RULES OF ELIGIBILITY, INDIVIDUALS ARE INELIGIBLE TO ASSESS AN APPLICATION IF THEY HAVE A PERSONAL, PROFESSIONAL, OR FINANCIAL INTEREST IN THE OUTCOME OF AN APPLICATION: FOR EXAMPLE, IF THE MEMBER SUPERVISES THE APPLICANT; IS EMPLOYED IN THE SCIENTIFIC UNIT OF WHICH THE APPLICANT IS A LEADER; OR IF THE MEMBER HAS A FAMILY RELATIONSHIP TO THE APPLICANT. NNF SYSTEMATICALLY COLLECTS DATA ON THE ACTIVITIES, OUTPUTS AND OUTCOMES OF EACH GRANT RECIPIENT'S PROJECT THROUGH ITS TWO ONLINE DATA-COLLECTION AND REPORTING SYSTEMS RESEARCHFISH AND FOUNDGOOD. THE TWO SYSTEMS ENABLE NNF TO SYSTEMATICALLY MONITOR THE ACTIVITIES OF ITS GRANT RECIPIENTS AND THE RESULTS OF THEIR WORK. SINCE ALL GRANT RECIPIENTS REPORT ANNUALLY, NNF HAS DATA ON THE FULL POPULATION WITH NO ATTRITION. IT IS MANDATORY FOR ALL GRANT RECIPIENTS TO USE NNF'S WEB-BASED SURVEY SYSTEMS (RESEARCHFISH AND FOUNDGOOD) FOR REPORTING ON ACTIVITIES AND RESULTS RELEVANT TO THEIR GRANT. THE GRANT RECIPIENTS REPORT ANNUALLY FOR THE DURATION OF THE PROJECT AND 1-5 YEARS AFTER THE PROJECT ENDS. NNF USES DATA IN EVALUATING TYPES OF GRANTS AND FUNDING INSTRUMENTS - WHAT WORKS AND WHAT DOES NOT WORK - TO SUPPORT THE BOARD IN ITS DECISIONS ON GRANT POLICY AND GRANT-AWARDING.
Schedule I (Form 990) 2023



Additional Data


Software ID:  
Software Version:  


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
medium right arrow graphic Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
medium right arrow graphic Attach to Form 990.
medium right arrow graphic Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2023
Open to Public Inspection
Name of the organization
NOVO NORDISK FONDEN
 
Employer identification number

98-1718091
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes on Line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .....
1b
Yes
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked on Line 1a? ....
2
Yes
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? .............
4a
 
No
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
 
No
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ....................
5a
 
No
b
Any related organization? .......................
5b
 
No
If "Yes," on line 5a or 5b, describe in Part III.
6
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ..................
6a
 
No
b
Any related organization? ......................
6b
 
No
If "Yes," on line 6a or 6b, describe in Part III.
7
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
 
No
8
Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................
8
 
No
9
If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2023

Schedule J (Form 990) 2023
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2, 1099-MISC compensation, and/or 1099-NEC (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation in column (B) reported as deferred on prior Form 990
(i) Base
compensation 		(ii) Bonus & incentive
compensation 		(iii) Other reportable compensation
1MADS KROGSGAARD THOMSEN
CEO 		(i)

(ii)		 757,607
-------------
0 		378,803
-------------
0 		26,651
-------------
0 		284,103
-------------
0 		0
-------------
0 		1,447,164
-------------
0 		0
-------------
0
2LARS REBIEN SORENSEN
CHAIR 		(i)

(ii)		 277,173
-------------
265,624 		0
-------------
0 		0
-------------
11,105 		0
-------------
0 		0
-------------
0 		277,173
-------------
276,729 		0
-------------
0
3SOREN NEDERGAARD
COO 		(i)

(ii)		 293,164
-------------
0 		146,582
-------------
0 		23,098
-------------
0 		61,564
-------------
0 		0
-------------
0 		524,408
-------------
0 		0
-------------
0
4STEEN RIISGAARD
DIRECTOR 		(i)

(ii)		 61,594
-------------
177,083 		0
-------------
0 		139,031
-------------
11,105 		0
-------------
0 		0
-------------
0 		200,625
-------------
188,188 		0
-------------
0
5ERIKA SODERBERG JOHNSSON
CFO 		(i)

(ii)		 346,466
-------------
0 		4,042
-------------
0 		23,098
-------------
0 		0
-------------
0 		0
-------------
0 		373,606
-------------
0 		0
-------------
0
Schedule J (Form 990) 2023

Schedule J (Form 990) 2023
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.
Return Reference Explanation
Schedule J (Form 990) 2023

Additional Data


Software ID:  
Software Version:  
SCHEDULE O
(Form 990)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
Attach to Form 990 or 990-EZ.
 Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2023
Open to Public
Inspection
Name of the organization
NOVO NORDISK FONDEN
 
Employer identification number

98-1718091
Return Reference Explanation
FORM 990, PART III, LINE 4A: AS OF 2023, NNF'S GRANTMAKING STRATEGY SETS FORTH THE FOLLOWING SEVEN GRANT-AWARDING FOCUS STRATEGIES AND LONG-TERM OBJECTIVES: - BIOMEDICAL AND HEALTH SCIENCE RESEARCH AND APPLICATIONS - TO ENABLE PEOPLE TO LIVE HEALTHIER AND BETTER LIVES BY FACILITATING RESEARCH THAT ADVANCES KNOWLEDGE OF HUMAN HEALTH AND DISEASE, SOLVES HEALTH CHALLENGES AND DEVELOPS THE HEALTHCARE SYSTEM. - BIOTECHNICAL - TO ACT FOR AND INSPIRE THE DEVELOPMENT OF A MORE SUSTAINABLE WORLD BY SUPPORTING RESEARCH THAT TRANSLATES INTO LIFE SCIENCE SOLUTIONS TO BENEFIT PEOPLE AND THE ENVIRONMENT. - INNOVATION - TO CREATE AND PROMOTE A LIFE SCIENCE ECOSYSTEM THAT INCREASES THE CAPACITY FOR RESEARCH INSTITUTIONS, CLINICS AND START-UPS TO MATURE AND TRANSLATE SCIENTIFIC DISCOVERIES INTO PRODUCTS AND SOLUTIONS FOR THE BENEFIT OF PEOPLE AND SOCIETY. - EDUCATION AND OUTREACH - TO SUPPORT GENERAL SCIENCE EDUCATION AND CULTIVATE SCIENTIFIC AND TECHNICAL COMPETENCIES AND ENGAGEMENT. - NATURAL AND TECHNICAL SCIENCE RESEARCH AND INTERDISCIPLINARITY - TO CATALYZE NATURAL AND TECHNICAL SCIENCE RESEARCH, PARTICULARLY IN FIELDS WITH POTENTIAL INTERDISCIPLINARY APPLICATION TO THE LIFE AND HEALTH SCIENCES AND INDUSTRIAL BIOTECHNOLOGY. MOVING FORWARD, NNF HAS THREE PILLARS: HEALTH, SUSTAINABILITY AND THE LIFE SCIENCE ECOSYSTEM. THE HEALTH PILLAR HAS THE GOAL OF IMPROVING THE LIVES OF PEOPLE BY PROGRESSING INNOVATION AND PREVENTION IN THE TREATMENT OF CARDIOMETABOLIC DISEASE AND INFECTIOUS DISEASE, WHICH WILL INCLUDE FIGHTING INEQUITY IN HEALTH AND STRENGTHENING EPIDEMIC PREPAREDNESS. THE SUSTAINABILITY PILLAR HAS THE GOAL OF IMPROVING THE SUSTAINABILITY OF SOCIETY BY ADVANCING KNOWLEDGE AND SOLUTIONS TO SUPPORT THE GREEN TRANSITION IN SOCIETY, WHICH WILL INCLUDE A FOCUS ADDRESSING CLIMATE CHANGE AND SUSTAINABLE AGRICULTURE AND FOOD. FINALLY, THE LIFE SCIENCE ECOSYSTEM PILLAR HAS THE GOAL OF INVESTING IN FUNDAMENTAL SCIENTIFIC RESEARCH, EDUCATION AND INNOVATION TO ENABLE A WORLD CLASS LIFE SCIENCE ECOSYSTEM.
FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY KPMG, NNF'S OUTSIDE ACCOUNTING FIRM, AND REVIEWED BY NNF'S INTERNAL TAX TEAM. THEN, THE FORM 990 IS APPROVED BY MANAGEMENT AND FILED AS REQUIRED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12C ANY ACTUAL OR POTENTIAL CONFLICTS OF INTEREST SHALL BE REPORTED TO THE EMPLOYEE'S MANAGER AS WELL AS THEIR P&O PARTNER OR THE NNF COMPLIANCE OFFICER IMMEDIATELY UPON DISCOVERY. MANAGERS AND THE NNF COMPLIANCE OFFICER ARE TO ENSURE NO EMPLOYEES WITH ACTUAL OR POTENTIAL CONFLICTS OF INTEREST ARE INVOLVED IN ANY RELEVANT DECISION-MAKING PROCESSES.
FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION REVIEW & APPROVAL PROCESS - DIRECTORS AND OFFICERS IN ESTABLISHING THE COMPENSATION OF THE ORGANIZATION'S DIRECTORS AND OFFICERS, INDEPENDENT COMPENSATION CONSULTANTS ARE UTILIZED, COMPENSATION STUDIES ARE COMPLETED TO GATHER COMPARATIVE DATA, PERSONS WITH A CONFLICT INTEREST REGARDING THE COMPENSATION ARRANGEMENTS AT ISSUE ARE NOT INVOLVED IN THE DECISION MAKING PROCESS, AND AMOUNTS ARE REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS. IN ADDITION, THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORD KEEPING FOR DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENTS.
FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC THROUGH THE ORGANIZATION'S WEBSITE AS WELL AS UPON REQUEST.
FORM 990, PART VII, SECTION A: NOVO NORDISK FONDEN (NNF) HAS DISCLOSED THE NAMES AND COMPENSATION OF ALL OF ITS DIRECTORS, OFFICERS, AND EMPLOYEES WITH SUBSTANTIAL INFLUENCE OVER ITS AFFAIRS WITHIN THE MEANING OF SECTION 4958(F)(1)(A). IT CANNOT, HOWEVER, PUBLICLY DISCLOSE THE COMPENSATION OF CERTAIN SUBJECT MATTER EXPERTS WHO FALL WITHIN THE INSTRUCTIONS' DEFINITIONS OF 'HIGHLY COMPENSATED EMPLOYEES' BECAUSE THIS INFORMATION SHOULD NOT BE PUBLICLY DISCLOSED PURSUANT TO THE DATA PROTECTION REGULATIONS WITHIN THE EUROPEAN UNION. THESE EXPERTS DO NOT HAVE SUBSTANTIAL INFLUENCE OR CONTROL OVER NNF AND THEIR COMPENSATION IS REASONABLE COMPENSATION NEGOTIATED AT ARM'S LENGTH AND CAN BE PROVIDED TO THE IRS UPON REQUEST.
FORM 990, PART XI, LINE 9: FX DIFFERENCE -34,740.
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990) 2023


Additional Data


Software ID:  
Software Version:  
SCHEDULE R
(Form 990)
Department of the Treasury
Internal Revenue Service
Related Organizations and Unrelated Partnerships
Complete if the organization answered "Yes" on Form 990, Part IV, line 33, 34, 35b, 36, or 37.
Attach to Form 990.
Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047
2023
Open to Public Inspection
Name of the organization
NOVO NORDISK FONDEN
 
Employer identification number

98-1718091
Part I
Identification of Disregarded Entities. Complete if the organization answered "Yes" on Form 990, Part IV, line 33.
(a)
Name, address, and EIN (if applicable) of disregarded entity


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Total income


 		(e)
End-of-year assets


 		(f)
Direct controlling
entity










Part II
Identification of Related Tax-Exempt Organizations. Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.
(a)
Name, address, and EIN of related organization


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Exempt Code section


 		(e)
Public charity status
(if section 501(c)(3))

 		(f)
Direct controlling
entity

 		(g)
Section 512(b)(13) controlled entity?
Yes No
(1)NOVO HOLDINGS AS
TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
98-0571483 		INVESTMENTS DA 501(C)(4)   NOVO NORDISK FONDEN
 
Yes
 












For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50135Y
Schedule R (Form 990) 2023
Schedule R (Form 990) 2023
Page 2
Part III
Identification of Related Organizations Taxable as a Partnership. Complete if the organization answered "Yes" on Form 990, Part IV, line 34, because it had one or more related organizations treated as a partnership during the tax year.
(a)
Name, address, and EIN of
related organization



 		(b)
Primary activity




 		(c)
Legal
domicile
(state or foreign
country)


 		(d)
Direct controlling
entity



 		(e)
Predominant income(related, unrelated, excluded from tax under sections 512-514)

(f)
Share of total income




 		(g)
Share of end-of-year
assets



 		(h)
Disproprtionate allocations?




 		(i)
Code V-UBI
amount in box 20 of
Schedule K-1
(Form 1065)
 		(j)
General or
managing
partner?



 		(k)
Percentage
ownership
Yes No Yes No
(1) NH KRONOS ULTIMATE HOLDINGS LP

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-3783511 		LIFE SCIENCES MA NOVO HOLDINGS AS
  		        No     No  
(2) AMALTHEA ACQUISITION I LP

ORANGE STREET
WILMINGTON,NC28401
86-2329070 		LIFE SCIENCES NC  
        No     No  
(3) AMALTHEA ACQUISITION II LP

ORANGE STREET
WILMINGTON,NC28401
86-2256617 		LIFE SCIENCES NC  
        No     No  
(4) NH KRONOS HOLDINGS LP

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-3799657 		LIFE SCIENCES MA  
        No     No  
(5) MAIA AGGREGATOR LP

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-3972659 		LIFE SCIENCES MA  
        No     No  
(6) NOVO MAIA LP

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-3953411 		LIFE SCIENCES MA NOVO HOLDINGS AS
  		        No     No  
(7) NOVO VENTURES 1 PS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
98-1030542 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		        No     No  
(8) NOVO CAPITAL INVESTORS PS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
98-1579797 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		        No     No  
(9) NOVO NORDISK PHARMACEUTICAL INDUSTRIES LP

ORANGE STREET
WILMINGTON,NC28401
56-1724716 		LIFE SCIENCES NC  
        No     No  
(10) NOVO RHEA AGGREGATOR LP

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
87-4778468 		LIFE SCIENCES MA  
        No     No  
(11) RHEA ACQUISITION HOLDINGS LP

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
87-4165568 		LIFE SCIENCES MA  
        No     No  
(12) RHEA INTERMEDIATE LP

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
87-4220683 		LIFE SCIENCES MA  
        No     No  
(13) EJENDOMSSELSKABET NOVO HOLDINGS PS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		        No     No  
(14) QUANTUM FOUNDY PS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO NORDISK FONDEN
  		RELATED -1,058,796 11,197,305   No   Yes   100.000 %
(15) NOVO NORDISK FOUNDATION CELLERATOR PS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO NORDISK FONDEN
  		RELATED       No   Yes   100.000 %
(16) NVAC PS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO NORDISK FONDEN
  		RELATED       No   Yes   100.000 %
Part IV
Identification of Related Organizations Taxable as a Corporation or Trust. Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.
(a)
Name, address, and EIN of
related organization
 		(b)
Primary activity
 		(c)
Legal
domicile
(state or foreign
country)
 		(d)
Direct controlling
entity
 		(e)
Type of entity
(C corp, S corp,
or trust) 		(f)
Share of total income
 		(g)
Share of end-of-year
assets
 		(h)
Percentage
ownership
 		(i)
Section 512(b)(13) controlled entity?
Yes No
(1) NOVO NORDISK AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(2) NOVO NORDISK PHARMA AG

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SZ  
C       Yes  
(3) NOVO NORDISK PHARMA GMBH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GM  
C       Yes  
(4) NOVO NORDISK (PTY) LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SF  
C       Yes  
(5) NOVO NORDISK PRODUCTION SAS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES FR  
C       Yes  
(6) NOVO NORDISK SCANDINAVIA AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES NO  
C       Yes  
(7) NOVO NORDISK SCANDINAVIA AB

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SW  
C       Yes  
(8) NOVO NORDISK FARMA OY

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES FI  
C       Yes  
(9) SA NOVO NORDISK PHARMA NV

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES BE  
C       Yes  
(10) NOVO NORDISK PHARMA SA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SP  
C       Yes  
(11) NOVO NORDISK PHARMA GMBH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES AU  
C       Yes  
(12) NOVO NORDISK BV

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES NL  
C       Yes  
(13) NOVO NORDISK LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(14) NOVO NORDISK HOLDING LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(15) NOVO NORDISK LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EI  
C       Yes  
(16) NOVO NORDISK HELLAS EPE

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GR  
C       Yes  
(17) NOVO NORDISK SAGLIK URUNLERI TIC LTD STI

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES TU  
C       Yes  
(18) NOVO NORDISK PHARMA LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES JA  
C       Yes  
(19) NOVO NORDISK SPA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IT  
C       Yes  
(20) NOVO NORDISK PHARMACEUTICALS AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(21) NOVO NORDISK CANADA INC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CA  
C       Yes  
(22) NOVO NORDISK COMERCIO PRODUTOS FARMACEUTICOS LDA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES PO  
C       Yes  
(23) NOVO NORDISK PHARMACEUTICALS PTY LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES AS  
C       Yes  
(24) NOVO NORDISK GSC HOLDING AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(25) NOVO NORDISK PHARMACEUTICALS (PHILIPPINES) INC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES RP  
C       Yes  
(26) NOVO NORDISK PHARMA (THAILAND) LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES TH  
C       Yes  
(27) NOVO NORDISK PHARMA KOREA LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES KS  
C       Yes  
(28) NOVO NORDISK PHARMA (TAIWAN) LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES TW  
C       Yes  
(29) NOVO NORDISK PHARMACEUTICAL SERVICES SPZOO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES PL  
C       Yes  
(30) NOVO NORDISK INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
06-1061602 		LIFE SCIENCES MA  
C       Yes  
(31) PT NOVO NORDISK INDONESIA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES ID  
C       Yes  
(32) NOVO NORDISK LIMITED LIABILITY COMPANY

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES RS  
C       Yes  
(33) ALDAPH SPA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES AG  
C       Yes  
(34) NOVO NORDISK

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES FR  
C       Yes  
(35) NOVO NORDISK (CHINA) PHARMACEUTICALS CO LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(36) NOVO NORDISK REGION JAPAN & KOREA AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(37) NNE PHARMAPLAN AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(38) NOVO NORDISK PRODUCAO FARMACEUTICA DO BRASIL LTDA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES BR  
C       Yes  
(39) NOVO NORDISK PHARMATECH AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(40) NOVO NORDISK HONG KONG LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES HK  
C       Yes  
(41) NOVO NORDISK REGION EUROPE AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(42) NOVO NORDISK REGION AAMEO AND LATAM AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(43) NOVO NORDISK EGYPT LLC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EG  
C       Yes  
(44) NOVO NORDISK PHARMACEUTICALS LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES NZ  
C       Yes  
(45) NOVO NORDISK FARMACEUTICA DO BRASIL LTDA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES BR  
C       Yes  
(46) NOVO NORDISK INDIA PRIVATE LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IN  
C       Yes  
(47) NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SN  
C       Yes  
(48) NOVO NORDISK PHARMA SPZOO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES PL  
C       Yes  
(49) NOVO NORDISK SRO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EZ  
C       Yes  
(50) NOVO NORDISK HUNGARIA KFT

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES HU  
C       Yes  
(51) NOVO NORDISK LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IS  
C       Yes  
(52) NOVO NORDISK PHARMA ARGENTINA SA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES AR  
C       Yes  
(53) NOVO NORDISK INVEST 2 AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(54) NOVO NORDISK PHARMA (MALAYSIA) SDN BHD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES MY  
C       Yes  
(55) NOVO INVESTMENTS PTE LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SN  
C       Yes  
(56) NOVO NORDISK MEXICO SA DE CV

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES MX  
C       Yes  
(57) NOVO NORDISK EGYPT TRADING

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EG  
C       Yes  
(58) NOVO NORDISK HEALTH CARE AG

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SZ  
C       Yes  
(59) NNE PHARMAPLAN AB

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SW  
C       Yes  
(60) NNE PHARMAPLAN INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
56-2009773 		LIFE SCIENCES NC  
C       Yes  
(61) NOVO NORDISK HRVATSKA DOO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES HR  
C       Yes  
(62) NOVO NORDISK EGYPT PHARMACEUTICALS LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EG  
C       Yes  
(63) NOVO NORDISK FARMA SRL

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES RO  
C       Yes  
(64) NOVO NORDISK PHARMA KISH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IR  
C       Yes  
(65) NOVO NORDISK TUNISIE SARL

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES TS  
C       Yes  
(66) NOVO NORDISK PHARMACEUTICA LIMITADA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CI  
C       Yes  
(67) NOVO NORDISK COLOMBIA SAS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CO  
C       Yes  
(68) NOVO NORDISK PHARMA EAD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES BU  
C       Yes  
(69) NOVO NORDISK PHARMA SAS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES MO  
C       Yes  
(70) NOVO NORDISK DOO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SI  
C       Yes  
(71) NOVO NORDISK SLOVAKIA SRO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES LO  
C       Yes  
(72) NOVO NORDISK (SHANGHAI) PHARMA TRADING CO LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(73) NOVO NORDISK PHARMA DOO BELGRADE (SERBIA)

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES RI  
C       Yes  
(74) NOVO NORDISK PHARMA GULF FZ-LLC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES AE  
C       Yes  
(75) NOVO NORDISK FARMA DOOEL

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES MK  
C       Yes  
(76) NOVO NORDISK PHARMA (PRIVATE) LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES PK  
C       Yes  
(77) NOVO NORDISK PHARMA (PRIVATE) LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES BG  
C       Yes  
(78) NOVO NORDISK PARS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IR  
C       Yes  
(79) UAB NOVO NORDISK PHARMA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES LH  
C       Yes  
(80) NOVO NORDISK PHARMA OPERATIONS AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(81) NOVO NORDISK PHARMA SARL

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES LE  
C       Yes  
(82) NOVO NORDISK PHARMA LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES NI  
C       Yes  
(83) NOVO NORDISK PHARMA OPERATIONS BAOS SDN BHD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES MY  
C       Yes  
(84) NNE PHARMAPLAN INDIA LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IN  
C       Yes  
(85) NNE PHARMAPLAN OOO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES RS  
C       Yes  
(86) NOVO NORDISK HAEMOPHILIA FOUNDATION

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SZ  
C       Yes  
(87) BEIJING NOVO NORDISK PHARMACEUTICALS SCIENCE AND TECHNOLOGY

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(88) NOVO NORDISK US HOLDINGS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
26-1528967 		LIFE SCIENCES MA  
C       Yes  
(89) NOVO NORDISK INVEST 4 AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(90) NOVO NORDISK PHARMA DOO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES BK  
C       Yes  
(91) NOVO NORDISK PRODUCTION SUPPORT LLC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES RS  
C       Yes  
(92) NOVO NORDISK SERVICE CENTRE (INDIA) PVT LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IN  
C       Yes  
(93) NOVO NORDISK REGION CHINA AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(94) NOVO NORDISK INVEST 3 AS - NOVO NORDISK AMERICA OPERATIONS AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(95) NOVO NORDISK PHARMA OPERATIONS AS - KOSOVO PE

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES KV  
C       Yes  
(96) NOVO NORDISK LANKA (PVT) LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CE  
C       Yes  
(97) NOVO NORDISK US BIO PRODUCTION INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
47-1644393 		LIFE SCIENCES MA  
C       Yes  
(98) NOVO NORDISK PHARMA TUNISIE

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES TS  
C       Yes  
(99) NOVO NORDISK RESEARCH CENTER INDIANAPOLIS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
47-5115548 		LIFE SCIENCES MA  
C       Yes  
(100) NN PANAMA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES PM  
C       Yes  
(101) NOVO NORDISK PHARMA OPERATIONS AS - IRAQ PE

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IZ  
C       Yes  
(102) NOVO NORDISK PHARMA OPERATIONS AS - ECUADOR PE

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EC  
C       Yes  
(103) NOVO NORDISK KENYA LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES KE  
C       Yes  
(104) NOVO NORDISK PERU SAC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES PE  
C       Yes  
(105) NOVO NORDISK REGION EUROPE PHARMACEUTICALS AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(106) NOVO NORDISK RESEARCH CENTER SEATTLE INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
82-1602938 		LIFE SCIENCES WA  
C       Yes  
(107) NOVO NORDISK US RESEARCH INVESTMENTS HOLDINGS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
82-2377582 		LIFE SCIENCES MA  
C       Yes  
(108) NOVO NORDISK MANUFACTURING OPERATIONS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
82-2377879 		LIFE SCIENCES MA  
C       Yes  
(109) NOVO NORDISK US MANUFACTURING HOLDINGS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
82-2377821 		LIFE SCIENCES MA  
C       Yes  
(110) NOVO NORDISK RESEARCH CENTRE OXFORD LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(111) NOVO NORDISK US COMMERCIAL HOLDINGS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
83-4173981 		LIFE SCIENCES MA  
C       Yes  
(112) NOVO NORDISK PHARMA INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
83-4174305 		LIFE SCIENCES NJ  
C       Yes  
(113) CORVIDIA THERAPEUTICS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
47-3297516 		LIFE SCIENCES MA  
C       Yes  
(114) NOVO NORDISK SAUDI FOR TRADING

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SA  
C       Yes  
(115) NOVO NORDISK PHARMATECH US INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
86-1657562 		LIFE SCIENCES MA  
C       Yes  
(116) NOVO NORDISK FINANCE (NETHERLANDS) BV

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES NL  
C       Yes  
(117) EMISPHERE TECHNOLOGIES INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
13-3306985 		LIFE SCIENCES NJ  
C       Yes  
(118) ELIMINATION - NEOTOPE NEUROSCIENCE LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EI  
C       Yes  
(119) NOVO NORDISK VENEZUELA CASA DE REPRESENTACIN CA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES VE  
C       Yes  
(120) DICERNA PHARMACEUTICALS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
20-5993609 		LIFE SCIENCES KY  
C       Yes  
(121) NOVO NORDISK VIETNAM LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES VM  
C       Yes  
(122) FORMA THERAPEUTICS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
26-0428600 		LIFE SCIENCES MA  
C       Yes  
(123) NOVO NORDISK KAZAKHSTAN LIMITED LIABILITY PARTNERS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES KZ  
C       Yes  
(124) NOVO NORDISK UKRAINE LIMITED LIABILITY COMPANY

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UP  
C       Yes  
(125) DIABETES FOUNDATION

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SP  
C       Yes  
(126) NOVO NORDISK EDUCATION FOUNDATION

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IN  
C       Yes  
(127) NNE PHARMAPLAN AS - NORWAY PE

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES NO  
C       Yes  
(128) NNE PHARMAPLAN AS - RUSSIA PE

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES RS  
C       Yes  
(129) NNE PHARMAPLAN AS - UNITED STATES PE

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
56-1853191 		LIFE SCIENCES NC  
C       Yes  
(130) DICERNA EU LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(131) DICERNA IRELAND LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EI  
C       Yes  
(132) DICERNA GERMANY GMBH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GM  
C       Yes  
(133) DICERNA SECURITY CORPORATION

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
30-0804982 		LIFE SCIENCES MA  
C       Yes  
(134) NOVOZYMES AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(135) NOVOZYMES BIOAG SA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES AR  
C       Yes  
(136) NOVOZYMES AUSTRALIA PTY LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES AS  
C       Yes  
(137) NOVOZYMES BELGIUM BVBA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES BE  
C       Yes  
(138) NOVOZYMES LATIN AMERICA LTDA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES BR  
C       Yes  
(139) NOVOZYMES BIOAG PRODUTOS PARA AGRICULTURA LTDA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES BR  
C       Yes  
(140) NOVOZYMES BIOAG LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CA  
C       Yes  
(141) NOVOZYMES CANADA LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CA  
C       Yes  
(142) SUZHOU HONGDA ENZYME CO LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(143) NOVOZYMES (CHINA) BIOTECHNOLOGY CO LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(144) NOVOZYMES (SHENYANG) BIOLOGICALS CO LT

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(145) NOVOZYMES (CHINA) INVESTMENT CO LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(146) NOVOZYMES BIOINDUSTRIAL AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(147) ALBUMEDIX AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(148) NOVOZYMES BIOAG AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(149) NOVOZYMES BIOINDUSTRIAL CHINA AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(150) NOVOZYMES FRANCE SAS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES FR  
C       Yes  
(151) NOVOZYMES DEUTSCHLAND GMBH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GM  
C       Yes  
(152) ORGANOBALANCE GMBH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GM  
C       Yes  
(153) NOVOZYMES SWITZERLAND AG

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GR  
C       Yes  
(154) NOVOZYMES HONG KONG LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES HK  
C       Yes  
(155) NOVOZYMES BIOPHARMA HONG KONG CO LTD (CLOSED)

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES HK  
C       Yes  
(156) PRECISIONBIOTICS GROUP LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EI  
C       Yes  
(157) NOVOZYMES SOUTH ASIA PRIVATE LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IN  
C       Yes  
(158) SYNERGIA LIFE SCIENCES PRIVATE LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IN  
C       Yes  
(159) NOVOZYMES ITALIA SRL

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IT  
C       Yes  
(160) NOVOZYMES JAPAN LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES JA  
C       Yes  
(161) NOVOZYMES KENYA LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES KE  
C       Yes  
(162) NOVOZYMES MALAYSIA SDN BHD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES MY  
C       Yes  
(163) NOVOZYMES MEXICO SA DE CV

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES MX  
C       Yes  
(164) NOVOZYMES MEXICANA SA DE CV

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES MX  
C       Yes  
(165) NOVOZYMES NETHERLANDS BV

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES NL  
C       Yes  
(166) NOVOYZMES AS POLISH PE

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES PL  
C       Yes  
(167) NOVOZYMES RUS LLC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES RS  
C       Yes  
(168) NOVOZYMES SINGAPORE PTE LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SN  
C       Yes  
(169) NOVOZYMES SA (PTY) LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SF  
C       Yes  
(170) NOVOZYMES KOREA LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES KS  
C       Yes  
(171) NOVOZYMES SPAIN SA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SP  
C       Yes  
(172) NOVOZYMES SWEDEN AB

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SW  
C       Yes  
(173) NOVOZYMES SWITZERLAND AG

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SZ  
C       Yes  
(174) NOVOZYMES SWITZERLAND HOLDING AG

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SZ  
C       Yes  
(175) NOVOZYMES (THAILAND) LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES TH  
C       Yes  
(176) NOVOZYMES ENZIM DIS TICARET LTD SIRKETI

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES TU  
C       Yes  
(177) NOVOZYMES UK LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(178) NOVOZYMES NORTH AMERICA INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
13-2639630 		LIFE SCIENCES NC  
C       Yes  
(179) NOVOZYMES INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
68-0263174 		LIFE SCIENCES CA  
C       Yes  
(180) NOVOZYMES BIOLOGICALS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
54-2042079 		LIFE SCIENCES VA  
C       Yes  
(181) NOVOZYMES BLAIR INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
26-2684092 		LIFE SCIENCES NE  
C       Yes  
(182) NOVOZYMES BIOAG INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
39-1657804 		LIFE SCIENCES WI  
C       Yes  
(183) NOVOZYMES US INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
68-0462786 		LIFE SCIENCES CA  
C       Yes  
(184) PHYSICIANS EXCLUSIVE LLC (DBA) MICROBIOME LABS

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
46-1448438 		LIFE SCIENCES IL  
C       Yes  
(185) NOVOZYMES ONEHEALTH BIOTECHNOLOGY (SHANGHAI) COMPANY LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(186) RIATA LIFE SCIENCES PRIVATE LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IN  
C       Yes  
(187) NOVOZYMES GREECE SMSA

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GR  
C       Yes  
(188) PT NOVOZYMES INDONESIA BIOTECHNOLOGY

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES ID  
C       Yes  
(189) ORBIS MEDICINES APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(190) ORBIS MEDICINES SA

ROUTE DE LA CORNICHE 6
EPALINGES   1066
SZ
99-9999999 		LIFE SCIENCES SZ  
C       Yes  
(191) RHEA GP LLC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
87-4398937 		LIFE SCIENCES MA  
C       Yes  
(192) RHEA PARENT INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
87-4142305 		LIFE SCIENCES MA  
C       Yes  
(193) THE RITEDOSE CORPORATION

TECHNOLOGY CIRCLE
COLUMBIA,MO65201
57-1023775 		LIFE SCIENCES MO  
C       Yes  
(194) TRC PROPCO INC

TECHNOLOGY CIRCLE
COLUMBIA,MO65201
26-3128331 		LIFE SCIENCES MO  
C       Yes  
(195) RITEDOSE PHARMACEUTICALS LLC

TECHNOLOGY CIRCLE
COLUMBIA,MO65201
27-3907624 		LIFE SCIENCES MO  
C       Yes  
(196) RIVA THERAPEUTICS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-2613056 		LIFE SCIENCES CA NOVO HOLDINGS AS
  		C       Yes  
(197) SONION HOLDCO AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(198) SONION AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(199) SONION NEDERLAND BV

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES NL  
C       Yes  
(200) SONION US INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
98-0685342 		LIFE SCIENCES IN  
C       Yes  
(201) SONION POLSKA SPZOO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES PL  
C       Yes  
(202) SONION VIETNAM LTD INC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES VM  
C       Yes  
(203) SONION VIETNAM II LTD INC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES VM  
C       Yes  
(204) SONION PHILIPPINES INC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES RP  
C       Yes  
(205) XILCO (CH) AG

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SZ  
C       Yes  
(206) SONION HOLDING AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(207) SONION INVESTCO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(208) XELLIA HOLDCO AS

DALSLANDSGADE 11
COPENHAGEN   2300
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(209) XELLIA PHARMACEUTICALS INC

150 E LAKE COOK RD
CHICAGO,IL60089
83-0504934 		LIFE SCIENCES IL  
C       Yes  
(210) XELLIA PHARMACEUTICALS USA LLC

1209 ORANGE STREET
CLEVELAND,OH19801
47-1150410 		LIFE SCIENCES OH  
C       Yes  
(211) CFT PHARMACEUTICALS LLC

150 E LAKE COOK RD
CHICAGO,IL60089
42-1774980 		LIFE SCIENCES IL  
C       Yes  
(212) CRANE PHARMACEUTICALS LLC

150 E LAKE COOK RD
CHICAGO,IL60089
99-9999999 		LIFE SCIENCES IL  
C       Yes  
(213) XELLIA PHARMACEUTICALS APS

DALSLANDSGADE 11
COPENHAGEN   2300
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(214) XELLIA GROUP APS

DALSLANDSGADE 11
COPENHAGEN   2300
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(215) NEW XELLIA GROUP AS

DALSLANDSGADE 11
COPENHAGEN   2300
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(216) NIPPON AXELLIA CO LTD

1-4-1 KANDA-SUDACHO
TOKYO   101-0041
JA
99-9999999 		LIFE SCIENCES JA  
C       Yes  
(217) XELLIA PHARMACEUTICALS LTD

SZALLAS U 1-3
BUDAPEST   1107
HU
99-9999999 		LIFE SCIENCES HU  
C       Yes  
(218) XELLIA (TAIZHOU) PHARMACEUTICALS CO LTD

108 BINHAI ROAD
TAIZHOU   318000
CH
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(219) XELLIA HONG KONG LIMITED

18 CHATER ROAD
HONG KONG    
HK
99-9999999 		LIFE SCIENCES HK  
C       Yes  
(220) XELLIA PHARMACEUTICALS AS

SILURVEIEN 2
OSLO   0380
NO
99-9999999 		LIFE SCIENCES NO  
C       Yes  
(221) OTNORTOPCO AS

SILURVEIEN 2
OSLO   0380
NO
99-9999999 		LIFE SCIENCES NO  
C       Yes  
(222) XELLIA GROUP AS

SILURVEIEN 2
OSLO   0380
NO
99-9999999 		LIFE SCIENCES NO  
C       Yes  
(223) XELLIA DOO CROATIA

SLAVONSKA AVENIJA 24/6
ZAGREB   10000
HR
99-9999999 		LIFE SCIENCES HR  
C       Yes  
(224) XELLIA PHARMACEUTICALS PRIVATE LTD - INDIA

1ST MAIN RD
BANGALORE   560078
IN
99-9999999 		LIFE SCIENCES IN  
C       Yes  
(225) XELLIA PHARMACEUTICALS SHANGHAI CO LTD

33 HUAYUANSHIQIAO ROAD
SHANGHAI    
CH
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(226) XELLIA PHARMACEUTICALS APS (BRANCH)

DSO-HQ-B4-410-02
DUBAI    
AE
99-9999999 		LIFE SCIENCES AE  
C       Yes  
(227) XELLIA PHARMACEUTICALS APS (BRANCH)

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES PM  
C       Yes  
(228) 21ST BIO AS

SYDMARKEN 42
SOBORG   2860
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(229) 21ST BIO INC

DREW AVENUE 1445
DAVIS,CA95618
36-4995664 		LIFE SCIENCES CA  
C       Yes  
(230) ACESION PHARMA APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(231) ALOOP THERAPEUTICS APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(232) ALTASCIENCES HOLDCO AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(233) AMALTHEA PARENT INC

ORANGE STREET
WILMINGTON,MA01887
86-2183514 		LIFE SCIENCES MA  
C       Yes  
(234) AMALTHEA UK LIMITED

BARTHOLOMEW LANE
LONDON    
UK
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(235) ALTASCIENCES PRECLINICAL SEATTLE LLC

MERRILL CREEK PARKWAY
EVERETT,WA98201
83-1352782 		LIFE SCIENCES WA  
C       Yes  
(236) ALTASCIENCES PRECLINICAL SCRANTON INC

DISCOVERY DRIVE
SCOTT TOWNSHIP,PA15017
36-4348604 		LIFE SCIENCES PA  
C       Yes  
(237) ALTASCIENCES CLINICAL LOS ANGELES INC

CERRITOS AVENUE
CYPRESS,CA90630
73-1732951 		LIFE SCIENCES CA  
C       Yes  
(238) ALTASCIENCES PROFESSIONAL LOS ANGELES PC

CERRITOS AVENUE
CYPRESS,CA90630
87-3490641 		LIFE SCIENCES CA  
C       Yes  
(239) ALTASCIENCES US ACQUISITION INC

ORANGE STREET
WILMINGTON,MA01887
82-1697220 		LIFE SCIENCES MA  
C       Yes  
(240) ALTASCIENCES USA LLC

ORANGE STREET
WILMINGTON,MA01887
26-2847752 		LIFE SCIENCES MA  
C       Yes  
(241) ALTASCIENCES CDMO PHILADELPHIA LLC

DELP DRIVE
HARLEYSVILLE,PA19438
26-2176590 		LIFE SCIENCES PA  
C       Yes  
(242) ALTASCIENCES CLINICAL FARGO LLC

ORANGE STREET
WILMINGTON,MA01887
38-3940620 		LIFE SCIENCES MA  
C       Yes  
(243) ALTASCIENCES CLINICAL KANSAS INC

METCALF AVENUE
OVERLAND PARK,KS66013
90-0980269 		LIFE SCIENCES KS  
C       Yes  
(244) ALTASCIENCES CLINICAL KANSAS PA

METCALF AVENUE
OVERLAND PARK,KS66013
43-1970398 		LIFE SCIENCES KS  
C       Yes  
(245) ALTASCIENCES HOLDINGS INC

ORANGE STREET
WILMINGTON,MA01887
84-4812001 		LIFE SCIENCES MA  
C       Yes  
(246) ALTASCIENCES REAL ESTATE LLC (FKA SINCLAIR REAL ESTATE LLC)

STATE ROAD DD
AUXVASSE,MO65231
26-3822368 		LIFE SCIENCES MO  
C       Yes  
(247) ALTASCIENCES MAINTENANCE LLC (FKA SINCLAIR MAINTENANCE LLC)

STATE ROAD DD
AUXVASSE,MO65231
26-3822307 		LIFE SCIENCES MO  
C       Yes  
(248) ALTASCIENCES PRECLINICAL COLUMBIA LLC (FKA SINCLAIR RESEARCH CENTER LLC)

STATE ROAD DD
AUXVASSE,MO65231
26-3789478 		LIFE SCIENCES MO  
C       Yes  
(249) SINCLAIR BIO PARENT LLC

STATE ROAD DD
AUXVASSE,MO65231
87-4142799 		LIFE SCIENCES MO  
C       Yes  
(250) PET FOOD SOLUTIONS LLC

STATE ROAD DD
AUXVASSE,MO65231
20-1133301 		LIFE SCIENCES MO  
C       Yes  
(251) SINCLAIR BIORESOURCES LLC

STATE ROAD DD
AUXVASSE,MO65231
30-0515757 		LIFE SCIENCES MO  
C       Yes  
(252) 9360-1318 QUEBEC INC

1 PLACE VILLE-MARIE
MONTREAL    
CA
99-9999999 		LIFE SCIENCES CA  
C       Yes  
(253) ALTASCIENCES COMPANY INC

ARMAND-FRAPPIER BLVD
LAVAL    
CA
99-9999999 		LIFE SCIENCES CA  
C       Yes  
(254) 9186-5238 QUEBEC INC

ARMAND-FRAPPIER BLVD
LAVAL    
CA
99-9999999 		LIFE SCIENCES CA  
C       Yes  
(255) AVAILITY HOLDCO AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(256) ARISTAEUS ACQUISITION HOLDINGS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
87-1409708 		LIFE SCIENCES MA  
C       Yes  
(257) ARISTAEUS BIDCO LLC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
87-1409455 		LIFE SCIENCES MA  
C       Yes  
(258) AV BLOCKER LLC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
82-3011956 		LIFE SCIENCES MA  
C       Yes  
(259) ARISTEA THERAPEUTICS INC

12770 HIGH BLUFF DR STE
SAN DIEGO,CA92130
87-1409708 		LIFE SCIENCES CA  
C       Yes  
(260) AVILEX PHARMA APS

OLE MAALOES VEJ
KOBENHAVN N   2200
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(261) BBI HOLDCO AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(262) BBI SOLUTIONS GROUP LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(263) BADUHENNA HOLDCO LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(264) BADUHENNA BIDCO LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(265) BBI ACQUISTION LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(266) BBI DIAGNOSTICS GROUP LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(267) BBI SOLUTIONS OEM LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(268) BBI RESOURCES LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(269) BBI DETECTION LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(270) NOVAURM DX LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(271) BBI ENZYMES (USA) LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(272) BBI GROUP HOLDCO LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(273) VECTOR BIDCO LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(274) BBI GROUP HOLDING LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(275) EAGLE SPV2 LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(276) EAGLE SPV3 LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(277) BBI USD LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(278) BBI UKP LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(279) ENZYMES LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(280) BBI BIOTECH (SHANGHAI) CO LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(281) BBI SOLUTIONS GMBH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GM  
C       Yes  
(282) DIARECT GMBH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GM  
C       Yes  
(283) BIOTEZ BERLIN-BUCH GMBH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GM  
C       Yes  
(284) STEFFENS BIOTECHNISCHE ANALYSEN GMBH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GM  
C       Yes  
(285) BBI ENZYMES SA (PTY) LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SF  
C       Yes  
(286) VISION BIOTECH (PTY) LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SF  
C       Yes  
(287) BBI US HOLDING LLC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
81-1953520 		LIFE SCIENCES MA  
C       Yes  
(288) BBI US GROUP LLC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
81-1954326 		LIFE SCIENCES MA  
C       Yes  
(289) BBI DETECTION LLC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
34-2050250 		LIFE SCIENCES OR  
C       Yes  
(290) MAINE BIOTECHNOLOGY SERVICES INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
01-0455916 		LIFE SCIENCES OR  
C       Yes  
(291) BIORIGIN APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(292) CLARIS BIOTHERAPEUTICS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
83-2060046 		LIFE SCIENCES NJ NOVO HOLDINGS AS
  		C       Yes  
(293) DADES AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(294) DADES CENTERBOX HOLDING APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(295) DADES ERHVERVBOLIG HOLDING APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(296) DADES CENTER ST APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(297) DADES CENTER VEST APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(298) DADES BOX APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(299) WAVES APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(300) DADES ERHVERV APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(301) FISKETORVET 2 ODENSE APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(302) RADHUSPLADSEN APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(303) DADES BOLIG APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(304) KOGE KYST 1 APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(305) SOEBORG EJENDOMME APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(306) SNEDKERHAVEN HVIDOVRE APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(307) BAEKKESKOVVEJ APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(308) SLOTSENGEN HILLEROD APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(309) KULTURPORTEN FARUM APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(310) COLOR 1 APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(311) CHRISTIANSVEJ GLOSTRUP APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(312) DADES 9 APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(313) DADES 4 APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(314) DADES 5 APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(315) DADES 10 APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(316) DADES 7 APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(317) DADES 8 APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(318) DADES 6 APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(319) ARYA BIDCO LTD

65 ST PAULS CHURCHYARD
LONDON   EC4M 8AB
UK
99-9999999 		LIFE SCIENCES UK NOVO HOLDINGS AS
  		C       Yes  
(320) HYPERBIO THERAPEUTICS APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(321) NH KRONOS GP LLC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-3821334 		LIFE SCIENCES MA NOVO HOLDINGS AS
  		C       Yes  
(322) NH KRONOS PARENT INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-3800560 		LIFE SCIENCES CA  
C       Yes  
(323) NH KRONOS INTERMEDIATE I INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-3821740 		LIFE SCIENCES CA  
C       Yes  
(324) NH KRONOS INTERMEDIATE II INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-3849199 		LIFE SCIENCES CA  
C       Yes  
(325) NH KRONOS INTERMEDIATE III INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-3894326 		LIFE SCIENCES CA  
C       Yes  
(326) NH KRONOS BUYER INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
88-3697794 		LIFE SCIENCES CA  
C       Yes  
(327) KABAFUSION HOLDINGS LLC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
27-3572421 		LIFE SCIENCES CA  
C       Yes  
(328) KABAFUSION INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
27-0202718 		LIFE SCIENCES MA  
C       Yes  
(329) STELLAR HEALTHCARE INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
42-1539166 		LIFE SCIENCES CA  
C       Yes  
(330) EDCO HOLDINGS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
75-2546510 		LIFE SCIENCES CA  
C       Yes  
(331) PRIVATE HOME CARE UNLIMITED INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
36-3712869 		LIFE SCIENCES IL  
C       Yes  
(332) PRE-MED INFUSION INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
36-3714633 		LIFE SCIENCES IL  
C       Yes  
(333) KABAFUSION INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
23-2229595 		LIFE SCIENCES CA  
C       Yes  
(334) MEDLINK HOME CARE INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
23-3308333 		LIFE SCIENCES CA  
C       Yes  
(335) GAMMA ACQUISITION INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
20-0146314 		LIFE SCIENCES CA  
C       Yes  
(336) LINCARE OF NEW YORK INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
59-3276378 		LIFE SCIENCES CA  
C       Yes  
(337) GTMI CORPORATION

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
47-1856692 		LIFE SCIENCES CA  
C       Yes  
(338) MAIA BLOCKER INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
87-4278660 		LIFE SCIENCES MA  
C       Yes  
(339) MAIA ACQUISITION HOLDINGS LLC

285 FULTON STREET
NEW YORK,NY10007
87-4255636 		LIFE SCIENCES NY  
C       Yes  
(340) MKG PHILOMENA BUYER INC

285 FULTON STREET
NEW YORK,NY10007
87-1090738 		LIFE SCIENCES NY  
C       Yes  
(341) MKG PHILOMENA OPCO LLC

285 FULTON STREET
NEW YORK,NY10007
87-1641174 		LIFE SCIENCES NY  
C       Yes  
(342) NNIT AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(343) NNIT (TIANJIN) TECHNOLOGY CO LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(344) NNIT INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
45-3769498 		LIFE SCIENCES NJ  
C       Yes  
(345) NNIT PHILIPPINES INC

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES RP  
C       Yes  
(346) NNIT GERMANY GMBH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES GM  
C       Yes  
(347) NNIT UK LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(348) NNIT SWITZERLAND AG

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SZ  
C       Yes  
(349) NNIT CZECH REPUBLIC SRO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EZ  
C       Yes  
(350) SCALES AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(351) VALIANCE PARTNERS LLC (MERGED INTO NNIT INC END OF 2022)

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
45-3769498 		LIFE SCIENCES NJ  
C       Yes  
(352) VALIANCE PARTNERS EUROPE LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EI  
C       Yes  
(353) NNIT POLAND SP Z OO

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES PL  
C       Yes  
(354) NNIT SINGAPORE HOLDING PTE LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SN  
C       Yes  
(355) NNIT SINGAPORE PTE LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SN  
C       Yes  
(356) PT HALFMANN GOETSCH PARTNER (CLOSED DOWN END OF 2022)

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES ID  
C       Yes  
(357) EXCELLIS HEALTH SOLUTIONS LLC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
27-1640052 		LIFE SCIENCES PA  
C       Yes  
(358) EXCELLIS EUROPE LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(359) EXCELLIS EUROPE LTD

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES UK  
C       Yes  
(360) SL CONTROLS LIMITED

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES EI  
C       Yes  
(361) SL CONTROLS USA INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
83-1461584 		LIFE SCIENCES FL  
C       Yes  
(362) PRIME4SERVICES ESP SL

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES SP  
C       Yes  
(363) NNIT ITALY SRL

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES IT  
C       Yes  
(364) NNIT(TIANJIN)TECHNOLOGY COLTD SHANGHAI BRANCH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(365) NNIT(TIANJIN)TECHNOLOGY COLTD BEIJING BRANCH

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(366) NEWCO IO AS (COMPANY SOLD IN MARCH 2023 AND RENAMED TO AEVEN AS)

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(367) ANTRAKA APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(368) NOVO INVEST 1 AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(369) ERT HOLDCO AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(370) ENV HOLDCO AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(371) NOVO INVEST 2A AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(372) KOMPLEMENTARSELSKABET NOVO CAPITAL INVESTORS APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(373) NOVO HOLDINGS INVEST ASIA AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(374) NOVO HOLDINGS US INC

501 2ND STREET
SAN FRANCISCO,CA94107
42-1691094 		LIFE SCIENCES CA NOVO HOLDINGS AS
  		C       Yes  
(375) NOVO DP 2 INC

501 2ND STREET
SAN FRANCISCO,CA94107
45-4035495 		LIFE SCIENCES CA NOVO HOLDINGS AS
  		C       Yes  
(376) NOVO ACCELERATOR INC

501 2ND STREET
SAN FRANCISCO,CA94107
84-2696952 		LIFE SCIENCES CA NOVO HOLDINGS AS
  		C       Yes  
(377) NOVO HOLDINGS EQUITY PTE LTD

152 BEACH ROAD 17-04
GATEWAY EAST   049909
SN
99-9999999 		LIFE SCIENCES SN NOVO HOLDINGS AS
  		C       Yes  
(378) INDKOBSSELSKABET NOVO HOLDINGS AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(379) NOVO 1999 ADVISORY SHANGHAI LTD

1515 WEST NANJING ROAD
SHANGHAI   200040
CH
99-9999999 		LIFE SCIENCES CH  
C       Yes  
(380) RITEDOSE HOLDCO AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(381) ECHO TOPCO AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO HOLDINGS AS
  		C       Yes  
(382) ECHO BIDCO AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA  
C       Yes  
(383) NNF GENERAL PARTNER APS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO NORDISK FONDEN
  		C -444 7,107 100.000 % Yes  
(384) NNF INDIA AS

TUBORG HAVNEVEJ 19
HELLERUP   2900
DA
99-9999999 		LIFE SCIENCES DA NOVO NORDISK FONDEN
  		C 15,547 230,843 100.000 % Yes  
(385) FORMA THERAPEUTICS HOLDINGS INC

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
37-1657129 		LIFE SCIENCES MA  
C       Yes  
(386) FORMA SECURITIES CORPORATION

200 CLARENDON STREET FLOOR 45
BOSTON,MA02116
84-4019370 		LIFE SCIENCES MA  
C       Yes  
Schedule R (Form 990) 2023
Schedule R (Form 990) 2023
Page 3
Part V
Transactions With Related Organizations. Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35b, or 36.
Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.
Yes
No
1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?
a Receipt of (i) interest, (ii) annuities, (iii) royalties, or (iv) rent from a controlled entity .....................
1a
 
No
b Gift, grant, or capital contribution to related organization(s) ............................
1b
Yes
 
c Gift, grant, or capital contribution from related organization(s) ............................
1c
Yes
 
d Loans or loan guarantees to or for related organization(s) ............................
1d
Yes
 
e Loans or loan guarantees by related organization(s) ............................
1e
 
No
f Dividends from related organization(s) ............................
1f
 
No
g Sale of assets to related organization(s) ............................
1g
 
No
h Purchase of assets from related organization(s) ............................
1h
 
No
i Exchange of assets with related organization(s) ............................
1i
 
No
j Lease of facilities, equipment, or other assets to related organization(s) .......................
1j
 
No
k Lease of facilities, equipment, or other assets from related organization(s) ......................
1k
Yes
 
l Performance of services or membership or fundraising solicitations for related organization(s) .....................
1l
Yes
 
m Performance of services or membership or fundraising solicitations by related organization(s) .................
1m
Yes
 
n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) ...................
1n
Yes
 
o Sharing of paid employees with related organization(s) ............................
1o
 
No
p Reimbursement paid to related organization(s) for expenses ............................
1p
 
No
q Reimbursement paid by related organization(s) for expenses ............................
1q
Yes
 
r Other transfer of cash or property to related organization(s) ............................
1r
 
No
s Other transfer of cash or property from related organization(s) ............................
1s
 
No
2
If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.
(a)
Name of related organization 		(b)
Transaction
type (a-s) 		(c)
Amount involved 		(d)
Method of determining amount involved
(1) NNF INDIA AS

 M 528,616 FMV
(2) NOVO HOLDINGS AS

 L 2,665,127 FMV
(3) NOVO HOLDINGS AS

 N 587,484,740 FMV
(4) NOVO HOLDINGS AS

 L 740,313 FMV
(5) NOVO HOLDINGS AS

 L 133,256 FMV
(6) NOVO HOLDINGS AS

 L 1,043,841 FMV
(7) NOVO HOLDINGS AS

 L 88,838 FMV
(8) NOVO HOLDINGS AS

 K 5,004,516 FMV
(9) NOVO HOLDINGS AS

 M 666,282 FMV
(10) NOVO HOLDINGS AS

 M 3,701,565 FMV
(11) NOVO HOLDINGS AS

 L 533,025 FMV
(12) NOVO HOLDINGS AS

 M 118,450 FMV
(13) NOVO HOLDINGS AS

 M 1,038,453 FMV
(14) NOVOZYMES AS

 M 75,897 FMV
(15) NNE AS

 M 150,137 FMV
(16) INDKOBSSELSKABET NOVO HOLDINGS AS

 Q 121,184 FMV
(17) NOVO HOLDINGS AS

 D 139,184,582 FMV
(18) NOVO HOLDINGS AS

 C 814,344,305 FMV
(19) QUANTUM FOUNDY PS

 B 59,225 FMV
(20) QUANTUM FOUNDY PS

 B 11,993,071 FMV
(21) NOVO NORDISK FOUNDATION CELLERATOR PS

 B 59,225 FMV
(22) NOVO NORDISK FOUNDATION CELLERATOR PS

 B 29,612,520 FMV
(23) NVAC PS

 B 59,225 FMV
Schedule R (Form 990) 2023
Schedule R (Form 990) 2023
Page 4
Part VI
Unrelated Organizations Taxable as a Partnership. Complete if the organization answered "Yes" on Form 990, Part IV, line 37.
Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.
(a)
Name, address, and EIN of entity 		(b)
Primary activity 		(c)
Legal domicile
(state or foreign
country) 		(d)
Predominant income (related, unrelated, excluded from tax under sections 512-514)

(e)
Are all partners
section
501(c)(3)
organizations? 		(f)
Share of total income




 		(g)
Share of
end-of-year
assets 		(h)
Disproprtionate allocations? 		(i)
Code V-UBI
amount in box 20
of Schedule K-1
(Form 1065) 		(j)
General or
managing
partner? 		(k)
Percentage
ownership
Yes No Yes No Yes No






























Schedule R (Form 990) 2023
Schedule R (Form 990) 2023
Page 5
Part VII
Supplemental Information
Provide additional information for responses to questions on Schedule R. See instructions.
Return Reference Explanation
Schedule R (Form 990) 2023

Additional Data


Software ID:  
Software Version: